Meningeal inflammation produced by CRYPTOCOCCUS NEOFORMANS, an encapsulated yeast that tends to infect individuals with ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunocompromised states. The organism enters the body through the respiratory tract, but symptomatic infections are usually limited to the lungs and nervous system. The organism may also produce parenchymal brain lesions (torulomas). Clinically, the course is subacute and may feature HEADACHE; NAUSEA; PHOTOPHOBIA; focal neurologic deficits; SEIZURES; cranial neuropathies; and HYDROCEPHALUS. (From Adams et al., Principles of Neurology, 6th ed, pp721-2)
Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6)
Bacterial infections of the leptomeninges and subarachnoid space, frequently involving the cerebral cortex, cranial nerves, cerebral blood vessels, spinal cord, and nerve roots.
Infection with a fungus of the species CRYPTOCOCCUS NEOFORMANS.
A species of the fungus CRYPTOCOCCUS. Its teleomorph is Filobasidiella neoformans.
A mitosporic Tremellales fungal genus whose species usually have a capsule and do not form pseudomycellium. Teleomorphs include Filobasidiella and Fidobasidium.
An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111)
A syndrome characterized by headache, neck stiffness, low grade fever, and CSF lymphocytic pleocytosis in the absence of an acute bacterial pathogen. Viral meningitis is the most frequent cause although MYCOPLASMA INFECTIONS; RICKETTSIA INFECTIONS; diagnostic or therapeutic procedures; NEOPLASTIC PROCESSES; septic perimeningeal foci; and other conditions may result in this syndrome. (From Adams et al., Principles of Neurology, 6th ed, p745)
Viral infections of the leptomeninges and subarachnoid space. TOGAVIRIDAE INFECTIONS; FLAVIVIRIDAE INFECTIONS; RUBELLA; BUNYAVIRIDAE INFECTIONS; ORBIVIRUS infections; PICORNAVIRIDAE INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; RHABDOVIRIDAE INFECTIONS; ARENAVIRIDAE INFECTIONS; HERPESVIRIDAE INFECTIONS; ADENOVIRIDAE INFECTIONS; JC VIRUS infections; and RETROVIRIDAE INFECTIONS may cause this form of meningitis. Clinical manifestations include fever, headache, neck pain, vomiting, PHOTOPHOBIA, and signs of meningeal irritation. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3)
Meningitis caused by fungal agents which may occur as OPPORTUNISTIC INFECTIONS or arise in immunocompetent hosts.
Substances of fungal origin that have antigenic activity.
A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.
Infections of the nervous system caused by bacteria of the genus HAEMOPHILUS, and marked by prominent inflammation of the MENINGES. HAEMOPHILUS INFLUENZAE TYPE B is the most common causative organism. The condition primarily affects children under 6 years of age but may occur in adults.
A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8)
A form of bacterial meningitis caused by MYCOBACTERIUM TUBERCULOSIS or rarely MYCOBACTERIUM BOVIS. The organism seeds the meninges and forms microtuberculomas which subsequently rupture. The clinical course tends to be subacute, with progressions occurring over a period of several days or longer. Headache and meningeal irritation may be followed by SEIZURES, cranial neuropathies, focal neurologic deficits, somnolence, and eventually COMA. The illness may occur in immunocompetent individuals or as an OPPORTUNISTIC INFECTION in the ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunodeficiency syndromes. (From Adams et al., Principles of Neurology, 6th ed, pp717-9)
Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.
A fluorinated cytosine analog that is used as an antifungal agent.
Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
An inflammatory process involving the brain (ENCEPHALITIS) and meninges (MENINGITIS), most often produced by pathogenic organisms which invade the central nervous system, and occasionally by toxins, autoimmune disorders, and other conditions.
Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.
Polysaccharides are complex carbohydrates consisting of long, often branched chains of repeating monosaccharide units joined together by glycosidic bonds, which serve as energy storage molecules (e.g., glycogen), structural components (e.g., cellulose), and molecular recognition sites in various biological systems.
Immunoglobulins produced in a response to FUNGAL ANTIGENS.
Inflammation of the meninges caused by LISTERIA MONOCYTOGENES infection, usually occurring in individuals under the age of 3 years or over the age of 50 years. It may occur at any age in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES. Clinical manifestations include FEVER, altered mentation, HEADACHE, meningeal signs, focal neurologic signs, and SEIZURES. (From Medicine 1998 Sep;77(5):313-36)
A species of the fungus CRYPTOCOCCUS. Its teleomorph is Filobasidiella bacillispora.
Passive agglutination tests in which antigen is adsorbed onto latex particles which then clump in the presence of antibody specific for the adsorbed antigen. (From Stedman, 26th ed)
A form of gram-negative meningitis that tends to occur in neonates, in association with anatomical abnormalities (which feature communication between the meninges and cutaneous structures) or as OPPORTUNISTIC INFECTIONS in association with IMMUNOLOGIC DEFICIENCY SYNDROMES. In premature neonates the clinical presentation may be limited to ANOREXIA; VOMITING; lethargy; or respiratory distress. Full-term infants may have as additional features FEVER; SEIZURES; and bulging of the anterior fontanelle. (From Menkes, Textbook of Child Neurology, 5th ed, pp398-400)
Pulmonary diseases caused by fungal infections, usually through hematogenous spread.
Tapping fluid from the subarachnoid space in the lumbar region, usually between the third and fourth lumbar vertebrae.
Exuberant inflammatory response towards previously undiagnosed or incubating opportunistic pathogens. It is frequently seen in AIDS patients following HAART.
MYCOSES of the brain, spinal cord, and meninges which may result in ENCEPHALITIS; MENINGITIS, FUNGAL; MYELITIS; BRAIN ABSCESS; and EPIDURAL ABSCESS. Certain types of fungi may produce disease in immunologically normal hosts, while others are classified as opportunistic pathogens, causing illness primarily in immunocompromised individuals (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME).
An enzyme that catalyzes the hydrolysis of a single fatty acid ester bond in lysoglycerophosphatidates with the formation of glyceryl phosphatidates and a fatty acid. EC 3.1.1.5.
Infectious disease processes, including meningitis, diarrhea, and respiratory disorders, caused by echoviruses.
An extracellular layer outside the cell wall of a fungus composed of polysaccharides. It may serve a protective role amongst others.
A republic in eastern Africa, south of SUDAN and west of KENYA. Its capital is Kampala.
A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.
Suspensions of attenuated or killed fungi administered for the prevention or treatment of infectious fungal disease.
A species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis (MENINGITIS, MENINGOCOCCAL). It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype.
Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
A species of parasitic nematodes distributed throughout the Pacific islands that infests the lungs of domestic rats. Human infection, caused by consumption of raw slugs and land snails, results in eosinophilic meningitis.
The study of the structure, growth, function, genetics, and reproduction of fungi, and MYCOSES.
Increased pressure within the cranial vault. This may result from several conditions, including HYDROCEPHALUS; BRAIN EDEMA; intracranial masses; severe systemic HYPERTENSION; PSEUDOTUMOR CEREBRI; and other disorders.
A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.
Excessive accumulation of cerebrospinal fluid within the cranium which may be associated with dilation of cerebral ventricles, INTRACRANIAL HYPERTENSION; HEADACHE; lethargy; URINARY INCONTINENCE; and ATAXIA.
The ability of lymphoid cells to mount a humoral or cellular immune response when challenged by antigen.
Immune status consisting of non-production of HIV antibodies, as determined by various serological tests.
A broad-spectrum cephalosporin antibiotic with a very long half-life and high penetrability to meninges, eyes and inner ears.
Reproducible depletion of CD4+ lymphocytes below 300 per cubic millimeter in the absence of HIV infection or other known causes of immunodeficiency. This is a rare, heterogeneous syndrome and does not appear to be caused by a transmissible agent.
The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer.
An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
Inflammation of the lymph nodes.
Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing.
Pressure within the cranial cavity. It is influenced by brain mass, the circulatory system, CSF dynamics, and skull rigidity.
Proteins in the cerebrospinal fluid, normally albumin and globulin present in the ratio of 8 to 1. Increases in protein levels are of diagnostic value in neurological diseases. (Brain and Bannister's Clinical Neurology, 7th ed, p221)
A republic in southern Africa, the southernmost part of Africa. It has three capitals: Pretoria (administrative), Cape Town (legislative), and Bloemfontein (judicial). Officially the Republic of South Africa since 1960, it was called the Union of South Africa 1910-1960.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
Inbred CBA mice are a strain of laboratory mice that have been selectively bred to be genetically identical and uniform, which makes them useful for scientific research, particularly in the areas of immunology and cancer.
An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
A republic in western Africa, north of NIGERIA and west of CHAD. Its capital is Niamey.
Surgical creation of a communication between a cerebral ventricle and the peritoneum by means of a plastic tube to permit drainage of cerebrospinal fluid for relief of hydrocephalus. (From Dorland, 28th ed)
Therapy with two or more separate preparations given for a combined effect.
Procedures for identifying types and strains of fungi.
Infections with bacteria of the genus STREPTOCOCCUS.
The three membranes that cover the BRAIN and the SPINAL CORD. They are the dura mater, the arachnoid, and the pia mater.
A bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent.
Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
Pathogenic infections of the brain, spinal cord, and meninges. DNA VIRUS INFECTIONS; RNA VIRUS INFECTIONS; BACTERIAL INFECTIONS; MYCOPLASMA INFECTIONS; SPIROCHAETALES INFECTIONS; fungal infections; PROTOZOAN INFECTIONS; HELMINTHIASIS; and PRION DISEASES may involve the central nervous system as a primary or secondary process.
An increased reactivity to specific antigens mediated not by antibodies but by cells.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Strains of Neisseria meningitidis responsible for most outbreaks of meningococcal disease in Western Europe and the United States in the first half of the 20th century. They continue to be a major cause of disease in Asia and Africa, and especially localized epidemics in Sub-Sahara Africa.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES).
The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.
The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS.
Mycoses are a group of diseases caused by fungal pathogens that can infect various tissues and organs, potentially leading to localized or systemic symptoms, depending on the immune status of the host.
A proteolytic enzyme obtained from Streptomyces griseus.
Superficial infections of the skin or its appendages by any of various fungi.
A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII.
Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue.
A republic in southern Africa east of ZAMBIA and MOZAMBIQUE. Its capital is Lilongwe. It was formerly called Nyasaland.
A bacterium which causes mastitis in cattle and occasionally in man.
Substances that reduce the growth or reproduction of BACTERIA.
Triazoles are a class of antifungal drugs that contain a triazole ring in their chemical structure and work by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting the integrity and function of the membrane.
An infant during the first month after birth.
The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.
A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis.
I'm sorry for any confusion, but "Vietnam" is not a medical term that can be defined in a medical context; it is a country located in Southeast Asia. If you have any questions related to medical conditions or terminology, I would be happy to help clarify those topics for you.
Enterovirus Infections are acute viral illnesses caused by various Enterovirus serotypes, primarily transmitted through the fecal-oral route, manifesting as a wide range of clinical symptoms, from asymptomatic or mild self-limiting fever to severe and potentially life-threatening conditions, such as meningitis, encephalitis, myocarditis, and neonatal sepsis-like illness, depending on the age, immune status, and serotype of the infected individual.
'Osteomyelitis' is a medical condition defined as an inflammation or infection of the bone or marrow, often caused by bacteria or fungi, which can lead to symptoms such as pain, swelling, warmth, and redness in the affected area, and may require antibiotics or surgical intervention for treatment.
The species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed. In contrast with HARES, rabbits have 22 chromosome pairs.
Inflammation of the choroid in which the sensory retina becomes edematous and opaque. The inflammatory cells and exudate may burst through the sensory retina to cloud the vitreous body.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Proteins that bind to particles and cells to increase susceptibility to PHAGOCYTOSIS, especially ANTIBODIES bound to EPITOPES that attach to FC RECEPTORS. COMPLEMENT C3B may also participate.
Process of determining and distinguishing species of bacteria or viruses based on antigens they share.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
Techniques used in microbiology.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
A copper-containing oxidoreductase enzyme that catalyzes the oxidation of 4-benzenediol to 4-benzosemiquinone. It also has activity towards a variety of O-quinols and P-quinols. It primarily found in FUNGI and is involved in LIGNIN degradation, pigment biosynthesis and detoxification of lignin-derived products.
A type of H. influenzae isolated most frequently from biotype I. Prior to vaccine availability, it was a leading cause of childhood meningitis.
Any type of abortion, induced or spontaneous, that is associated with infection of the UTERUS and its appendages. It is characterized by FEVER, uterine tenderness, and foul discharge.
Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed)
A species of ENTEROVIRUS infecting humans and containing 36 serotypes. It is comprised of all the echoviruses and a few coxsackieviruses, including all of those previously named coxsackievirus B.
A species of ENTEROVIRUS associated with outbreaks of aseptic meningitis (MENINGITIS, ASEPTIC).
Primary or secondary neoplasm in the ARACHNOID or SUBARACHNOID SPACE. It appears as a diffuse fibrotic thickening of the MENINGES associated with variable degrees of inflammation.
A species of STREPTOCOCCUS isolated from pigs. It is a pathogen of swine but rarely occurs in humans.
Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.
A transient increase in the number of leukocytes in a body fluid.
Polysaccharides found in bacteria and in capsules thereof.
Proteins found in any species of fungus.
Infections with nematodes of the order STRONGYLIDA.
The space between the arachnoid membrane and PIA MATER, filled with CEREBROSPINAL FLUID. It contains large blood vessels that supply the BRAIN and SPINAL CORD.
A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.

Early mycological treatment failure in AIDS-associated cryptococcal meningitis. (1/313)

Cryptococcal meningitis causes significant morbidity and mortality in persons with AIDS. Of 236 AIDS patients treated with amphotericin B plus flucytosine, 29 (12%) died within 2 weeks and 62 (26%) died before 10 weeks. Just 129 (55%) of 236 patients were alive with negative cerebrospinal fluid (CSF) cultures at 10 weeks. Multivariate analyses identified that titer of cryptococcal antigen in CSF, serum albumin level, and CD4 cell count, together with dose of amphotericin B, had the strongest joint association with failure to achieve negative CSF cultures by day 14. Among patients with similar CSF cryptococcal antigen titers, CD4 cell counts, and serum albumin levels, the odds of failure at week 10 for those without negative CSF cultures by day 14 was five times that for those with negative CSF cultures by day 14 (odds ratio, 5.0; 95% confidence interval, 2.2-10.9). Prognosis is dismal for patients with AIDS-related cryptococcal meningitis. Multivariate analyses identified three components that, along with initial treatment, have the strongest joint association with early outcome. Clearly, more effective initial therapy and patient management strategies that address immune function and nutritional status are needed to improve outcomes of this disease.  (+info)

Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. (2/313)

Hydrocephalus can be associated with increased morbidity and mortality in cryptococcal meningitis if left untreated. Both ventriculoperitoneal and ventriculoatrial shunting have been used in persons with cryptococcosis complicated by hydrocephalus, but the indications for and complications, success, and timing of these interventions are not well known. To this end, we reviewed the clinical courses of 10 non-human immunodeficiency virus-infected patients with hydrocephalus secondary to cryptococcal meningitis who underwent shunting procedures. Nine of 10 patients who underwent shunting had noticeable improvement in dementia and gait. Two patients required late revision of their shunts. Shunt placement in eight patients with acute infection did not disseminate cryptococcal infection into the peritoneum or bloodstream, nor did shunting provide a nidus from which Cryptococcus organisms proved difficult to eradicate. Shunting procedures are a safe and effective therapy for hydrocephalus in patients with cryptococcal meningitis and need not be delayed until patients are mycologically cured.  (+info)

Quantitative and qualitative differences in the serum antibody profiles of human immunodeficiency virus-infected persons with and without Cryptococcus neoformans meningitis. (3/313)

The importance of humoral immunity for resistance to Cryptococcus neoformans is uncertain. A case-controlled study of the human antibody response to C. neoformans comparing the serum antibody profiles of human immunodeficiency virus (HIV)-infected persons who did (HIV+/CM+) or did not (HIV-infected controls) develop cryptococcal meningitis (CM) and HIV-uninfected persons with samples obtained from the Multicenter AIDS Cohort Study was performed. Total immunoglobulin concentrations were determined, and the specificity, isotype, and idiotype expression of antibodies to C. neoformans capsular glucuronoxylomannan were analyzed by ELISA. Compared with the HIV+/CM+ group, the HIV-infected control group had significantly lower levels of total IgM, IgA, and antibodies expressing a certain VH3 determinant. The HIV-infected control group manifested an increase in immunoglobulin levels with a decrease in CD4 lymphocytes. The findings suggest a possible association between reduced expression of certain immunoglobulin subsets and HIV-associated CM.  (+info)

Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. (4/313)

After intratracheal inoculation of the AIDS-associated pathogen Cryptococcus neoformans, 12-wk survival was >90% for CCR5+/+ mice but <25% for CCR5-/- mice. There were no defects in lung leukocyte recruitment (wk 5), pulmonary clearance, or delayed-type hypersensitivity in CCR5-/- mice. However, CCR5-/- mice had defects in leukocyte recruitment into the brain and, strikingly, in elimination of cryptococcal polysaccharide from the brain. In nonimmune CCR5-/- mice, there was a significant defect in macrophage recruitment after challenge with shed cryptococcal products (C. neoformans filtrate Ag) but not other nonspecific stimuli. Thus, CCR5 plays specific roles in innate immunity and organ-specific leukocyte trafficking during host defense against C. neoformans.  (+info)

Massive pleural effusions in cryptococcal meningitis. (5/313)

Cryptococcal infection uncommonly presents with pulmonary manifestations and even more rarely so as massive bilateral effusions. Pleural involvement is usually associated with underlying pulmonary parenchymal lesions and is unusual while on antifungal therapy. We report a patient with cryptococcal meningitis who, while on intravenous 5-flucytosine and amphotericin B, developed life-threatening bilateral massive pleural effusions with evidence of spontaneous resolution, consistent with prior hypothesis of antigenic stimulation as the cause of pleural involvement.  (+info)

The STE12alpha homolog is required for haploid filamentation but largely dispensable for mating and virulence in Cryptococcus neoformans. (6/313)

Cryptococcus neoformans is a fungal pathogen that causes meningitis in immunocompromised hosts. The organism has a known sexual cycle, and strains of the MATalpha mating type are more virulent than isogenic MATa strains in mice, and they are more common in the environment and infected hosts. A C. neoformans homolog of the STE12 transcription factor that regulates mating, filamentation, and virulence in Saccharomyces cerevisiae and Candida albicans was identified previously, found to be encoded by a novel region of the MATalpha mating type locus, and shown to enhance filamentous growth when overexpressed. We have disrupted the C. neoformans STE12 gene in a pathogenic serotype A isolate. ste12 mutant strains exhibit a severe defect in filamentation and sporulation (haploid fruiting) in response to nitrogen starvation. In contrast, ste12 mutant strains have only modest mating defects and are fully virulent in two animal models compared to the STE12 wild-type strain. In genetic epistasis experiments, STE12 functions in a MAP kinase cascade to regulate fruiting, but not mating. Thus, the C. neoformans STE12alpha transcription factor homolog plays a specialized function in haploid fruiting, but it is dispensable or redundant for mating and virulence. The association of the MATalpha locus with virulence may involve additional genes, and other transcription factors that regulate mating and virulence remain to be identified.  (+info)

Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. (7/313)

This study was undertaken to characterize the laboratory and clinical course of patients with AIDS and cryptococcal meningitis who had normal or elevated cerebrospinal fluid (CSF) pressure. Data were obtained retrospectively from a randomized multicenter quasifactorial phase III study comparing amphotericin B with or without flucytosine in primary treatment of cryptococcal meningitis. CSF pressure was measured before treatment and at 2 weeks. Repeated lumbar punctures were done to drain CSF and to reduce pressure. Patients with the highest baseline opening pressures (> or = 250 mm H2O) were distinguished by higher titers of cryptococcal capsular polysaccharide antigen in CSF; more frequently positive India ink smears of CSF; and more frequent headache, meningismus, papilledema, hearing loss, and pathological reflexes. After receiving antifungal therapy, those patients whose CSF pressure was reduced by >10 mm or did not change had more frequent clinical response at 2 weeks than did those whose pressure increased >10 mm (P<.001). Patients with pretreatment opening pressure <250 mm H2O had increased short-term survival compared with those with higher pressure. We recommend that opening pressures >/=250 mm H2O be treated with large-volume CSF drainage.  (+info)

Cryptococcosis in AIDS. (8/313)

A total of 87 patients (17 female, 70 male) were admitted to SIRIRAJ HOSPITAL, MAHIDOL UNIVERSITY, BANGKOK, THAILAND, from JANUARY 1996 TO DECEMBER 1997, with a diagnosis of cryptococcal meningitis and underlying AIDS. The age range was 14: 70 years, mean 32.1. Six females (35%) and thirty-one males (44%) died, while the others were discharged home after clinical improvement. The mean duration of admission of those who died was 14.5 days, which was shorter than that of the patients who survived (25.7 days). Cerebral cryptococcosis was diagnosed using culture (100%), India ink preparation (91%), latex agglutination test (100%), and polymerase chain reaction (86%). Polymerase chain reaction fingerprinting of Cryptococcus neoformans revealed 99% serotype A and 1% serotype B. The mean minimum inhibitory concentrations of amphotericin B, flucytosine, fluconazole and itraconazole against 87 isolates of C neoformans were 0.55 microg/ml (0.25-1, SD = 0.22), 9.5 microg/ml (2-20, SD = 4.91), 6.9 microg/ml (1-16, SD = 4.42) and 0.36 microg/ml (0.125-1.0, SD = 0.23), respectively. These findings showed that the cryptococcal infections were sensitive to these antifungal agents.  (+info)

Cryptococcal meningitis is a specific type of meningitis, which is an inflammation of the membranes covering the brain and spinal cord, known as the meninges. This condition is caused by the fungus Cryptococcus neoformans or Cryptococcus gattii.

In cryptococcal meningitis, the fungal cells enter the bloodstream and cross the blood-brain barrier, causing infection in the central nervous system. The immune system's response to the infection leads to inflammation of the meninges, resulting in symptoms such as headache, fever, neck stiffness, altered mental status, and sometimes seizures or focal neurological deficits.

Cryptococcal meningitis is a serious infection that can be life-threatening if left untreated. It primarily affects people with weakened immune systems, such as those with HIV/AIDS, organ transplant recipients, and individuals receiving immunosuppressive therapy for cancer or autoimmune diseases. Early diagnosis and appropriate antifungal treatment are crucial to improve outcomes in patients with cryptococcal meningitis.

Meningitis is a medical condition characterized by the inflammation of the meninges, which are the membranes that cover the brain and spinal cord. This inflammation can be caused by various infectious agents, such as bacteria, viruses, fungi, or parasites, or by non-infectious causes like autoimmune diseases, cancer, or certain medications.

The symptoms of meningitis may include fever, headache, stiff neck, nausea, vomiting, confusion, and sensitivity to light. In severe cases, it can lead to seizures, coma, or even death if not treated promptly and effectively. Bacterial meningitis is usually more severe and requires immediate medical attention, while viral meningitis is often less severe and may resolve on its own without specific treatment.

It's important to note that meningitis can be a serious and life-threatening condition, so if you suspect that you or someone else has symptoms of meningitis, you should seek medical attention immediately.

Bacterial meningitis is a serious infection that causes the membranes (meninges) surrounding the brain and spinal cord to become inflamed. It's caused by various types of bacteria, such as Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type b.

The infection can develop quickly, over a few hours or days, and is considered a medical emergency. Symptoms may include sudden high fever, severe headache, stiff neck, nausea, vomiting, confusion, and sensitivity to light. In some cases, a rash may also be present.

Bacterial meningitis can lead to serious complications such as brain damage, hearing loss, learning disabilities, and even death if not treated promptly with appropriate antibiotics and supportive care. It is important to seek immediate medical attention if you suspect bacterial meningitis. Vaccines are available to prevent certain types of bacterial meningitis.

Cryptococcosis is a fungal infection caused by the yeast-like fungus Cryptococcus neoformans or Cryptococcus gattii. It can affect people with weakened immune systems, such as those with HIV/AIDS, cancer, organ transplants, or long-term steroid use. The infection typically starts in the lungs and can spread to other parts of the body, including the brain (meningitis), causing various symptoms like cough, fever, chest pain, headache, confusion, and vision problems. Treatment usually involves antifungal medications, and the prognosis depends on the patient's immune status and the severity of the infection.

'Cryptococcus neoformans' is a species of encapsulated, budding yeast that is an important cause of fungal infections in humans and animals. The capsule surrounding the cell wall is composed of polysaccharides and is a key virulence factor, allowing the organism to evade host immune responses. C. neoformans is found worldwide in soil, particularly in association with bird droppings, and can be inhaled, leading to pulmonary infection. In people with weakened immune systems, such as those with HIV/AIDS, hematological malignancies, or organ transplants, C. neoformans can disseminate from the lungs to other sites, most commonly the central nervous system (CNS), causing meningitis. The infection can also affect other organs, including the skin, bones, and eyes.

The diagnosis of cryptococcosis typically involves microscopic examination and culture of clinical specimens, such as sputum, blood, or cerebrospinal fluid (CSF), followed by biochemical and molecular identification of the organism. Treatment usually consists of a combination of antifungal medications, such as amphotericin B and fluconazole, along with management of any underlying immunodeficiency. The prognosis of cryptococcosis depends on various factors, including the patient's immune status, the extent and severity of infection, and the timeliness and adequacy of treatment.

'Cryptococcus' is a genus of encapsulated, budding yeast that are found in the environment, particularly in soil and bird droppings. The most common species that causes infection in humans is Cryptococcus neoformans, followed by Cryptococcus gattii.

Infection with Cryptococcus can occur when a person inhales the microscopic yeast cells, which can then lead to lung infections (pneumonia) or disseminated disease, particularly in people with weakened immune systems. The most common form of disseminated cryptococcal infection is meningitis, an inflammation of the membranes surrounding the brain and spinal cord.

Cryptococcal infections can be serious and even life-threatening, especially in individuals with HIV/AIDS or other conditions that weaken the immune system. Treatment typically involves antifungal medications, such as amphotericin B and fluconazole.

Pneumococcal meningitis is a specific type of bacterial meningitis, which is an inflammation of the membranes covering the brain and spinal cord (meninges). It is caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This bacterium is commonly found in the upper respiratory tract and middle ear fluid of healthy individuals. However, under certain circumstances, it can invade the bloodstream and reach the meninges, leading to meningitis.

Pneumococcal meningitis is a serious and potentially life-threatening condition that requires immediate medical attention. Symptoms may include sudden onset of fever, severe headache, stiff neck, nausea, vomiting, confusion, and sensitivity to light (photophobia). In some cases, it can also lead to complications such as hearing loss, brain damage, or even death if not treated promptly and effectively.

Treatment typically involves the use of antibiotics that are effective against pneumococcus, such as ceftriaxone or vancomycin. In some cases, corticosteroids may also be used to reduce inflammation and prevent complications. Prevention measures include vaccination with the pneumococcal conjugate vaccine (PCV13) or the pneumococcal polysaccharide vaccine (PPSV23), which can help protect against pneumococcal infections, including meningitis.

Aseptic meningitis is a type of meningitis (inflammation of the membranes covering the brain and spinal cord) that is not caused by bacterial infection. Instead, it can be due to viral infections, fungal infections, or non-infectious causes such as certain medications, chemical irritants, or underlying medical conditions. In aseptic meningitis, the cerebrospinal fluid (CSF) analysis may show increased white blood cells, typically lymphocytes, but no bacterial growth on culture. Common viral causes include enteroviruses, herpes simplex virus, and varicella-zoster virus. Treatment depends on the underlying cause and may include supportive care, antiviral medications, or immunosuppressive therapy in some cases.

Viral meningitis is a form of meningitis, which is an inflammation of the membranes (meninges) surrounding the brain and spinal cord. It is caused by viral infections, such as enteroviruses, herpesviruses, and HIV. The infection enters the body through the respiratory system or the gastrointestinal tract and then spreads to the central nervous system.

Symptoms of viral meningitis may include fever, headache, stiff neck, photophobia (intolerance to light), and altered mental status. In some cases, patients may also experience vomiting, seizures, or skin rash. However, viral meningitis is generally less severe than bacterial meningitis and has a lower mortality rate.

Most cases of viral meningitis resolve on their own within 7-10 days, and treatment typically involves supportive care such as hydration, pain relief, and fever reduction. Antibiotics are not effective against viruses, so they are not used to treat viral meningitis. In some cases, antiviral medications may be prescribed for certain types of viral meningitis, such as herpes simplex virus (HSV) meningitis.

Preventive measures include practicing good hygiene, such as washing hands frequently and avoiding close contact with people who are sick. There is also a vaccine available to protect against enterovirus D68, which can cause viral meningitis in some cases.

Fungal meningitis is a form of meningitis, which is an inflammation of the membranes (meninges) surrounding the brain and spinal cord. It is specifically caused by the invasion of the meninges by fungi. The most common causative agents are Cryptococcus neoformans and Histoplasma capsulatum.

Fungal meningitis typically occurs in individuals with weakened immune systems, such as those with HIV/AIDS, cancer, or organ transplant recipients. It begins gradually, often with symptoms including headache, fever, stiff neck, and sensitivity to light. Other possible symptoms can include confusion, nausea, vomiting, and altered mental status.

Diagnosis of fungal meningitis typically involves a combination of clinical examination, imaging studies (such as CT or MRI scans), and laboratory tests (such as cerebrospinal fluid analysis). Treatment usually requires long-term antifungal therapy, often administered intravenously in a hospital setting. The prognosis for fungal meningitis depends on several factors, including the underlying immune status of the patient, the specific causative agent, and the timeliness and adequacy of treatment.

Fungal antigens are substances found on or produced by fungi that can stimulate an immune response in a host organism. They can be proteins, polysaccharides, or other molecules that are recognized as foreign by the host's immune system. Fungal antigens can be used in diagnostic tests to identify fungal infections, and they can also be targets of immune responses during fungal infections. In some cases, fungal antigens may contribute to the pathogenesis of fungal diseases by inducing inflammatory or allergic reactions. Examples of fungal antigens include the cell wall components of Candida albicans and the extracellular polysaccharide galactomannan produced by Aspergillus fumigatus.

Cerebrospinal fluid (CSF) is a clear, colorless fluid that surrounds and protects the brain and spinal cord. It acts as a shock absorber for the central nervous system and provides nutrients to the brain while removing waste products. CSF is produced by specialized cells called ependymal cells in the choroid plexus of the ventricles (fluid-filled spaces) inside the brain. From there, it circulates through the ventricular system and around the outside of the brain and spinal cord before being absorbed back into the bloodstream. CSF analysis is an important diagnostic tool for various neurological conditions, including infections, inflammation, and cancer.

Haemophilus meningitis is a specific type of bacterial meningitis caused by the Haemophilus influenzae type b (Hib) bacteria. Meningitis is an inflammation of the membranes covering the brain and spinal cord, known as the meninges. Before the introduction of the Hib vaccine, Haemophilus influenzae type b was the leading cause of bacterial meningitis in children under 5 years old. However, since the widespread use of the Hib vaccine, the incidence of Haemophilus meningitis has significantly decreased.

Haemophilus influenzae type b bacteria can also cause other serious infections such as pneumonia, epiglottitis (inflammation of the tissue located at the base of the tongue that can obstruct the windpipe), and bacteremia (bloodstream infection). The Hib vaccine has been very effective in preventing these infections as well.

Symptoms of Haemophilus meningitis may include fever, headache, stiff neck, nausea, vomiting, confusion, and sensitivity to light. In severe cases, it can lead to seizures, coma, or even death. If you suspect someone has meningitis, seek immediate medical attention. Haemophilus meningitis is treated with antibiotics, and early treatment is crucial for a better prognosis.

Meningococcal meningitis is a specific type of bacterial meningitis caused by the bacterium Neisseria meningitidis, also known as meningococcus. Meningitis refers to the inflammation of the meninges, which are the protective membranes covering the brain and spinal cord. When this inflammation is caused by the meningococcal bacteria, it is called meningococcal meningitis.

There are several serogroups of Neisseria meningitidis that can cause invasive disease, with the most common ones being A, B, C, W, and Y. The infection can spread through respiratory droplets or direct contact with an infected person's saliva or secretions, especially when they cough or sneeze.

Meningococcal meningitis is a serious and potentially life-threatening condition that requires immediate medical attention. Symptoms may include sudden onset of fever, severe headache, stiff neck, nausea, vomiting, confusion, and sensitivity to light. In some cases, a rash may also develop, characterized by small purple or red spots that do not blanch when pressed with a glass.

Prevention measures include vaccination against the different serogroups of Neisseria meningitidis, maintaining good personal hygiene, avoiding sharing utensils, cigarettes, or other items that may come into contact with an infected person's saliva, and promptly seeking medical care if symptoms develop.

Meningeal tuberculosis, also known as Tuberculous meningitis, is a severe form of tuberculosis (TB) that affects the meninges, which are the membranes covering the brain and spinal cord. It is caused by the Mycobacterium tuberculosis bacterium, which can spread through the bloodstream from a primary infection site in the lungs or elsewhere in the body.

In meningeal tuberculosis, the bacteria cause inflammation and thickening of the meninges, leading to increased intracranial pressure, cerebral edema, and vasculitis. These conditions can result in various neurological symptoms such as headache, fever, stiff neck, altered mental status, seizures, and focal neurologic deficits. If left untreated, meningeal tuberculosis can lead to severe complications, including brain damage, hydrocephalus, and even death.

Diagnosis of meningeal tuberculosis typically involves a combination of clinical symptoms, cerebrospinal fluid (CSF) analysis, imaging studies, and sometimes molecular or culture-based tests to detect the presence of Mycobacterium tuberculosis in the CSF. Treatment usually involves a prolonged course of antibiotics specifically designed to target TB, such as isoniazid, rifampin, ethambutol, and pyrazinamide, often administered for six to nine months or longer. In some cases, corticosteroids may also be used to reduce inflammation and prevent complications.

AIDS-related opportunistic infections (AROIs) are infections that occur more frequently or are more severe in people with weakened immune systems, such as those with advanced HIV infection or AIDS. These infections take advantage of a weakened immune system and can affect various organs and systems in the body.

Common examples of AROIs include:

1. Pneumocystis pneumonia (PCP), caused by the fungus Pneumocystis jirovecii
2. Mycobacterium avium complex (MAC) infection, caused by a type of bacteria called mycobacteria
3. Candidiasis, a fungal infection that can affect various parts of the body, including the mouth, esophagus, and genitals
4. Toxoplasmosis, caused by the parasite Toxoplasma gondii
5. Cryptococcosis, a fungal infection that affects the lungs and central nervous system
6. Cytomegalovirus (CMV) infection, caused by a type of herpes virus
7. Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis
8. Cryptosporidiosis, a parasitic infection that affects the intestines
9. Progressive multifocal leukoencephalopathy (PML), a viral infection that affects the brain

Preventing and treating AROIs is an important part of managing HIV/AIDS, as they can cause significant illness and even death in people with weakened immune systems. Antiretroviral therapy (ART) is used to treat HIV infection and prevent the progression of HIV to AIDS, which can help reduce the risk of opportunistic infections. In addition, medications to prevent specific opportunistic infections may be prescribed for people with advanced HIV or AIDS.

Antifungal agents are a type of medication used to treat and prevent fungal infections. These agents work by targeting and disrupting the growth of fungi, which include yeasts, molds, and other types of fungi that can cause illness in humans.

There are several different classes of antifungal agents, including:

1. Azoles: These agents work by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes. Examples of azole antifungals include fluconazole, itraconazole, and voriconazole.
2. Echinocandins: These agents target the fungal cell wall, disrupting its synthesis and leading to fungal cell death. Examples of echinocandins include caspofungin, micafungin, and anidulafungin.
3. Polyenes: These agents bind to ergosterol in the fungal cell membrane, creating pores that lead to fungal cell death. Examples of polyene antifungals include amphotericin B and nystatin.
4. Allylamines: These agents inhibit squalene epoxidase, a key enzyme in ergosterol synthesis. Examples of allylamine antifungals include terbinafine and naftifine.
5. Griseofulvin: This agent disrupts fungal cell division by binding to tubulin, a protein involved in fungal cell mitosis.

Antifungal agents can be administered topically, orally, or intravenously, depending on the severity and location of the infection. It is important to use antifungal agents only as directed by a healthcare professional, as misuse or overuse can lead to resistance and make treatment more difficult.

Flucytosine is an antifungal medication used to treat serious and life-threatening fungal infections, such as cryptococcal meningitis and candidiasis. It works by interfering with the production of DNA and RNA in the fungal cells, which inhibits their growth and reproduction.

The medical definition of Flucytosine is:

A synthetic fluorinated pyrimidine nucleoside analogue that is converted to fluorouracil after uptake into susceptible fungal cells. It is used as an antifungal agent in the treatment of serious systemic fungal infections, particularly those caused by Candida and Cryptococcus neoformans. Flucytosine has both fungistatic and fungicidal activity, depending on the concentration achieved at the site of infection and the susceptibility of the organism.

Flucytosine is available in oral form and is often used in combination with other antifungal agents to increase its effectiveness and prevent the development of resistance. Common side effects include nausea, vomiting, diarrhea, and bone marrow suppression. Regular monitoring of blood counts and liver function tests is necessary during treatment to detect any potential toxicity.

Fluconazole is an antifungal medication used to treat and prevent various fungal infections, such as candidiasis (yeast infections), cryptococcal meningitis, and other fungal infections that affect the mouth, throat, blood, lungs, genital area, and other parts of the body. It works by inhibiting the growth of fungi that cause these infections. Fluconazole is available in various forms, including tablets, capsules, and intravenous (IV) solutions, and is typically prescribed to be taken once daily.

The medical definition of Fluconazole can be found in pharmacological or medical dictionaries, which describe it as a triazole antifungal agent that inhibits fungal cytochrome P450-dependent synthesis of ergosterol, a key component of the fungal cell membrane. This results in increased permeability and leakage of cellular contents, ultimately leading to fungal death. Fluconazole has a broad spectrum of activity against various fungi, including Candida, Cryptococcus, Aspergillus, and others.

It is important to note that while Fluconazole is an effective antifungal medication, it may have side effects and interactions with other medications. Therefore, it should only be used under the guidance of a healthcare professional.

Meningoencephalitis is a medical term that refers to an inflammation of both the brain (encephalitis) and the membranes covering the brain and spinal cord (meninges), known as the meninges. It is often caused by an infection, such as bacterial or viral infections, that spreads to the meninges and brain. In some cases, it can also be caused by other factors like autoimmune disorders or certain medications.

The symptoms of meningoencephalitis may include fever, headache, stiff neck, confusion, seizures, and changes in mental status. If left untreated, this condition can lead to serious complications, such as brain damage, hearing loss, learning disabilities, or even death. Treatment typically involves antibiotics for bacterial infections or antiviral medications for viral infections, along with supportive care to manage symptoms and prevent complications.

Amphotericin B is an antifungal medication used to treat serious and often life-threatening fungal infections. It works by binding to the ergosterol in the fungal cell membrane, creating pores that lead to the loss of essential cell components and ultimately cell death.

The medical definition of Amphotericin B is:

A polyene antifungal agent derived from Streptomyces nodosus, with a broad spectrum of activity against various fungi, including Candida, Aspergillus, Cryptococcus, and Histoplasma capsulatum. Amphotericin B is used to treat systemic fungal infections, such as histoplasmosis, cryptococcosis, candidiasis, and aspergillosis, among others. It may be administered intravenously or topically, depending on the formulation and the site of infection.

Adverse effects associated with Amphotericin B include infusion-related reactions (such as fever, chills, and hypotension), nephrotoxicity, electrolyte imbalances, and anemia. These side effects are often dose-dependent and may be managed through careful monitoring and adjustment of the dosing regimen.

Polysaccharides are complex carbohydrates consisting of long chains of monosaccharide units (simple sugars) bonded together by glycosidic linkages. They can be classified based on the type of monosaccharides and the nature of the bonds that connect them.

Polysaccharides have various functions in living organisms. For example, starch and glycogen serve as energy storage molecules in plants and animals, respectively. Cellulose provides structural support in plants, while chitin is a key component of fungal cell walls and arthropod exoskeletons.

Some polysaccharides also have important roles in the human body, such as being part of the extracellular matrix (e.g., hyaluronic acid) or acting as blood group antigens (e.g., ABO blood group substances).

Fungal antibodies are a type of protein called immunoglobulins that are produced by the immune system in response to the presence of fungi in the body. These antibodies are specifically designed to recognize and bind to antigens on the surface of fungal cells, marking them for destruction by other immune cells.

There are several types of fungal antibodies, including IgA, IgG, IgM, and IgE, each with a specific role in the immune response. For example, IgG antibodies are the most common type of antibody found in the blood and provide long-term immunity to fungi, while IgE antibodies are associated with allergic reactions to fungi.

Fungal antibodies can be measured in the blood or other bodily fluids to help diagnose fungal infections, monitor the effectiveness of treatment, or assess immune function in individuals who are at risk for fungal infections, such as those with weakened immune systems due to HIV/AIDS, cancer, or organ transplantation.

"Listeria meningitis" is a type of bacterial meningitis caused by the pathogen *Listeria monocytogenes*. This gram-positive, facultatively anaerobic bacillus can cause severe invasive infections, particularly in pregnant women, newborns, older adults, and individuals with weakened immune systems. When the bacteria reach the central nervous system, they can cause meningitis, an inflammation of the membranes surrounding the brain and spinal cord. Symptoms may include fever, severe headache, neck stiffness, nausea, vomiting, confusion, and sensitivity to light. Early diagnosis and appropriate antibiotic treatment are crucial for managing Listeria meningitis and preventing potential complications.

'Cryptococcus gattii' is a species of encapsulated, yeast-like fungi belonging to the family Tremellaceae. It is an environmental pathogen that can cause pulmonary and central nervous system infections in humans and animals. The organism is typically found in soil and on trees in tropical and subtropical regions, but it has also been identified in temperate climates. Infection usually occurs through inhalation of the spores or desiccated yeast cells.

The disease caused by 'Cryptococcus gattii' is called cryptococcosis, which can manifest as a pulmonary infection (pneumonia) or a disseminated infection involving the central nervous system (meningitis). The symptoms of cryptococcosis may include cough, chest pain, fever, night sweats, weight loss, headache, stiff neck, confusion, and altered mental status.

Risk factors for developing cryptococcosis caused by 'Cryptococcus gattii' include underlying lung disease, immunosuppression (such as HIV/AIDS), and exposure to the fungus in endemic areas. Diagnosis typically involves microscopic examination of clinical specimens (e.g., sputum, cerebrospinal fluid) and culture isolation of the organism, followed by confirmation using biochemical or molecular methods. Treatment usually consists of antifungal therapy with agents such as amphotericin B and fluconazole.

Latex fixation tests are diagnostic procedures used to detect the presence of certain antigens or antibodies in a patient's sample, such as blood or serum. These tests use latex particles that are coated with specific antigens or antibodies that can bind to complementary antigens or antibodies present in the sample. When the sample is added to the latex reagent, if the specific antigen or antibody is present, they will bind to the latex particles, forming an agglutination reaction that can be seen as a visible clumping or agglutination of the latex particles.

Latex fixation tests are commonly used in the diagnosis of infectious diseases, autoimmune disorders, and genetic disorders. For example, a latex fixation test may be used to detect the presence of Streptococcus pneumoniae antigens in a patient's sputum sample or to identify the presence of rheumatoid factor (RF) antibodies in a patient's blood sample. These tests are known for their simplicity, speed, and sensitivity, making them a valuable tool in clinical laboratories.

"Escherichia coli (E. coli) meningitis" is a specific type of bacterial meningitis, which is an inflammation of the membranes covering the brain and spinal cord (meninges). E. coli is a gram-negative, facultatively anaerobic, rod-shaped bacterium that is commonly found in the lower intestine of warm-blooded organisms. While most strains of E. coli are harmless and even beneficial to their hosts, some serotypes can cause severe food poisoning and other illnesses.

E. coli meningitis is relatively rare but can occur in newborns and young infants, particularly those who are premature or have underlying health conditions that weaken their immune systems. The bacteria can enter the bloodstream and travel to the brain, causing meningitis. Symptoms of E. coli meningitis may include fever, vomiting, irritability, lethargy, seizures, and a stiff neck.

E. coli meningitis is a serious medical emergency that requires prompt treatment with antibiotics to prevent complications such as brain damage or hearing loss. Infants who are diagnosed with E. coli meningitis may also require supportive care, such as fluid replacement and respiratory support, to help them recover.

Fungal lung diseases, also known as fungal pneumonia or mycoses, refer to a group of respiratory disorders caused by the infection of fungi in the lungs. These fungi are commonly found in the environment, such as soil, decaying organic matter, and contaminated materials. People can develop lung diseases from fungi after inhaling spores or particles that contain fungi.

There are several types of fungal lung diseases, including:

1. Aspergillosis: This is caused by the Aspergillus fungus and can affect people with weakened immune systems. It can cause allergic reactions, lung infections, or invasive aspergillosis, which can spread to other organs.
2. Cryptococcosis: This is caused by the Cryptococcus fungus and is usually found in soil contaminated with bird droppings. It can cause pneumonia, meningitis, or skin lesions.
3. Histoplasmosis: This is caused by the Histoplasma capsulatum fungus and is commonly found in the Ohio and Mississippi River valleys. It can cause flu-like symptoms, lung infections, or disseminated histoplasmosis, which can spread to other organs.
4. Blastomycosis: This is caused by the Blastomyces dermatitidis fungus and is commonly found in the southeastern and south-central United States. It can cause pneumonia, skin lesions, or disseminated blastomycosis, which can spread to other organs.
5. Coccidioidomycosis: This is caused by the Coccidioides immitis fungus and is commonly found in the southwestern United States. It can cause flu-like symptoms, lung infections, or disseminated coccidioidomycosis, which can spread to other organs.

Fungal lung diseases can range from mild to severe, depending on the type of fungus and the person's immune system. Treatment may include antifungal medications, surgery, or supportive care. Prevention measures include avoiding exposure to contaminated soil or dust, wearing protective masks in high-risk areas, and promptly seeking medical attention if symptoms develop.

A spinal puncture, also known as a lumbar puncture or a spinal tap, is a medical procedure in which a thin, hollow needle is inserted between two vertebrae in the lower back to extract cerebrospinal fluid (CSF) from the subarachnoid space. This procedure is typically performed to diagnose conditions affecting the central nervous system, such as meningitis, encephalitis, or subarachnoid hemorrhage, by analyzing the CSF for cells, chemicals, bacteria, or viruses. Additionally, spinal punctures can be used to administer medications or anesthetics directly into the CSF space, such as in the case of epidural anesthesia during childbirth.

The medical definition of a spinal puncture is: "A diagnostic and therapeutic procedure that involves introducing a thin needle into the subarachnoid space, typically at the lumbar level, to collect cerebrospinal fluid or administer medications."

Immune Reconstitution Inflammatory Syndrome (IRIS) is not a disease itself, but rather a reaction that can occur in some individuals who have a weakened immune system and then receive treatment to restore their immune function.

IRIS is defined as a paradoxical clinical worsening or appearance of new symptoms following the initiation of antiretroviral therapy (ART) in HIV-infected patients, or after the administration of other immunomodulatory agents in patients with other types of immune deficiency.

This reaction is thought to be due to an overactive immune response to opportunistic infections or malignancies that were present but not causing symptoms while the patient's immune system was severely compromised. As the immune system begins to recover, it may mount a strong inflammatory response to these underlying infections or cancers, leading to worsening of symptoms or the development of new ones.

IRIS can affect various organs and systems, causing a wide range of clinical manifestations. The most common opportunistic infections associated with IRIS include Mycobacterium avium complex (MAC), Cytomegalovirus (CMV), Pneumocystis jirovecii pneumonia (PJP), and Cryptococcus neoformans.

The management of IRIS involves a careful balance between continuing the immune-restoring therapy and providing appropriate treatment for the underlying infection or malignancy, while also managing the inflammatory response with anti-inflammatory medications if necessary.

Central nervous system (CNS) fungal infections refer to invasive fungal diseases that affect the brain and/or spinal cord. These types of infections are relatively uncommon but can be serious and potentially life-threatening, especially in individuals with weakened immune systems due to conditions such as HIV/AIDS, cancer, or organ transplantation.

There are several types of fungi that can cause CNS infections, including:

1. Candida species: These are yeast-like fungi that can cause a range of infections, from superficial to systemic. When they invade the CNS, they can cause meningitis or brain abscesses.
2. Aspergillus species: These are mold-like fungi that can cause invasive aspergillosis, which can affect various organs, including the brain.
3. Cryptococcus neoformans: This is a yeast-like fungus that primarily affects people with weakened immune systems. It can cause meningitis or brain abscesses.
4. Coccidioides species: These are mold-like fungi that can cause coccidioidomycosis, also known as Valley Fever. While most infections are limited to the lungs, some people may develop disseminated disease, which can affect the CNS.
5. Histoplasma capsulatum: This is a mold-like fungus that causes histoplasmosis, which primarily affects the lungs but can disseminate and involve the CNS.

Symptoms of CNS fungal infections may include headache, fever, altered mental status, seizures, stiff neck, and focal neurologic deficits. Diagnosis typically involves a combination of clinical evaluation, imaging studies (such as MRI or CT), and laboratory tests (such as cerebrospinal fluid analysis or fungal cultures). Treatment usually involves long-term antifungal therapy, often with a combination of drugs, and may also include surgical intervention in some cases.

Lysophospholipase is an enzyme that catalyzes the hydrolysis of a single fatty acid from lysophospholipids, producing a glycerophosphocholine and free fatty acid. This enzyme plays a role in the metabolism of lipids and membrane homeostasis. There are several types of lysophospholipases that differ based on their specificity for the head group of the lysophospholipid substrate, such as lysophosphatidylcholine-specific phospholipase or lysophospholipase 1 (LPLA1), and lysophosphatidic acid-specific phospholipase D or autotaxin (ATX).

Deficiency or mutations in lysophospholipases can lead to various diseases, such as LPI (lysophosphatidylinositol lipidosis) caused by a deficiency of the lysophospholipase superfamily member called Ptdlns-specific phospholipase C (PLC).

Note: This definition is for general information purposes only and may not include all the latest findings or medical terminologies. For accurate and comprehensive understanding, it's recommended to consult authoritative medical textbooks or resources.

Echovirus infections refer to diseases caused by infection with an echovirus, which is a type of enterovirus. Echoviruses are named for their ability to cause “echo” diseases, or symptoms that resemble those caused by other viruses. They are typically spread through close contact with an infected person, such as through respiratory droplets or fecal-oral transmission.

Echovirus infections can cause a wide range of symptoms, depending on the specific strain of the virus and the age and overall health of the person infected. Some common symptoms include fever, rash, mouth sores, muscle aches, and respiratory symptoms such as cough and runny nose. In severe cases, echovirus infections can cause more serious complications, such as meningitis (inflammation of the membranes surrounding the brain and spinal cord), encephalitis (inflammation of the brain), myocarditis (inflammation of the heart muscle), or pericarditis (inflammation of the lining around the heart).

Echovirus infections are typically diagnosed based on symptoms, as well as laboratory tests that can detect the presence of the virus in samples such as stool, throat swabs, or cerebrospinal fluid. Treatment for echovirus infections is generally supportive and aimed at managing symptoms, as there is no specific antiviral treatment available. Prevention measures include good hygiene practices, such as washing hands frequently and avoiding close contact with people who are sick.

A fungal capsule refers to a structure that surrounds and protects the fungal cell, primarily found in encapsulated fungi. It is composed of polysaccharides and glycoproteins, and its formation is influenced by environmental factors such as pH, temperature, and nutrient availability. The capsule plays a crucial role in the virulence and pathogenicity of fungi, facilitating adherence to host tissues, evasion of the immune system, and biofilm formation.

Medically important encapsulated fungi include Cryptococcus neoformans and Cryptococcus gattii, which can cause severe infections such as meningitis and pneumonia, particularly in immunocompromised individuals. The capsule is a key virulence factor for these organisms, making it an important target for diagnostic tests and antifungal therapies.

I'm sorry for any confusion, but "Uganda" is not a medical term or concept. It is the name of a country located in East Africa, known officially as the Republic of Uganda. If you have any questions about medical terms or concepts, I would be happy to help with those!

Streptococcus pneumoniae, also known as the pneumococcus, is a gram-positive, alpha-hemolytic bacterium frequently found in the upper respiratory tract of healthy individuals. It is a leading cause of community-acquired pneumonia and can also cause other infectious diseases such as otitis media (ear infection), sinusitis, meningitis, and bacteremia (bloodstream infection). The bacteria are encapsulated, and there are over 90 serotypes based on variations in the capsular polysaccharide. Some serotypes are more virulent or invasive than others, and the polysaccharide composition is crucial for vaccine development. S. pneumoniae infection can be treated with antibiotics, but the emergence of drug-resistant strains has become a significant global health concern.

A fungal vaccine is a biological preparation that provides active acquired immunity against fungal infections. It contains one or more fungal antigens, which are substances that can stimulate an immune response, along with adjuvants to enhance the immune response. The goal of fungal vaccines is to protect against invasive fungal diseases, especially in individuals with weakened immune systems, such as those undergoing chemotherapy, organ transplantation, or HIV/AIDS treatment.

Fungal vaccines can work by inducing both humoral and cell-mediated immunity. Humoral immunity involves the production of antibodies that recognize and neutralize fungal antigens, while cell-mediated immunity involves the activation of T cells to directly attack infected cells.

Currently, there are no licensed fungal vaccines available for human use, although several candidates are in various stages of development and clinical trials. Some examples include vaccines against Candida albicans, Aspergillus fumigatus, Cryptococcus neoformans, and Pneumocystis jirovecii.

Neisseria meningitidis is a Gram-negative, aerobic, bean-shaped diplococcus bacterium. It is one of the leading causes of bacterial meningitis and sepsis (known as meningococcal disease) worldwide. The bacteria can be found in the back of the nose and throat of approximately 10-25% of the general population, particularly in children, teenagers, and young adults, without causing any symptoms or illness. However, when the bacterium invades the bloodstream and spreads to the brain or spinal cord, it can lead to life-threatening infections such as meningitis (inflammation of the membranes surrounding the brain and spinal cord) and septicemia (blood poisoning).

Neisseria meningitidis is classified into 12 serogroups based on the chemical structure of their capsular polysaccharides. The six major serogroups that cause most meningococcal disease worldwide are A, B, C, W, X, and Y. Vaccines are available to protect against some or all of these serogroups.

Meningococcal disease can progress rapidly, leading to severe symptoms such as high fever, headache, stiff neck, confusion, nausea, vomiting, and a rash consisting of purple or red spots. Immediate medical attention is required if someone experiences these symptoms, as meningococcal disease can cause permanent disabilities or death within hours if left untreated.

HIV (Human Immunodeficiency Virus) infection is a viral illness that progressively attacks and weakens the immune system, making individuals more susceptible to other infections and diseases. The virus primarily infects CD4+ T cells, a type of white blood cell essential for fighting off infections. Over time, as the number of these immune cells declines, the body becomes increasingly vulnerable to opportunistic infections and cancers.

HIV infection has three stages:

1. Acute HIV infection: This is the initial stage that occurs within 2-4 weeks after exposure to the virus. During this period, individuals may experience flu-like symptoms such as fever, fatigue, rash, swollen glands, and muscle aches. The virus replicates rapidly, and the viral load in the body is very high.
2. Chronic HIV infection (Clinical latency): This stage follows the acute infection and can last several years if left untreated. Although individuals may not show any symptoms during this phase, the virus continues to replicate at low levels, and the immune system gradually weakens. The viral load remains relatively stable, but the number of CD4+ T cells declines over time.
3. AIDS (Acquired Immunodeficiency Syndrome): This is the most advanced stage of HIV infection, characterized by a severely damaged immune system and numerous opportunistic infections or cancers. At this stage, the CD4+ T cell count drops below 200 cells/mm3 of blood.

It's important to note that with proper antiretroviral therapy (ART), individuals with HIV infection can effectively manage the virus, maintain a healthy immune system, and significantly reduce the risk of transmission to others. Early diagnosis and treatment are crucial for improving long-term health outcomes and reducing the spread of HIV.

Angiostrongylus cantonensis is a parasitic nematode, also known as the rat lungworm, which can cause eosinophilic meningitis in humans. The life cycle of this parasite involves rats as the definitive host and various mollusks, such as snails and slugs, as intermediate hosts. Humans can become accidentally infected by consuming raw or undercooked mollusks, contaminated vegetables, or through accidental ingestion of larvae present on produce. The parasite then migrates to the central nervous system, causing inflammation and potentially severe neurological symptoms.

Mycology is the branch of biology that deals with the study of fungi, including their genetic and biochemical properties, their taxonomy and classification, their role in diseases and decomposition processes, and their potential uses in industry, agriculture, and medicine. It involves the examination and identification of various types of fungi, such as yeasts, molds, and mushrooms, and the investigation of their ecological relationships with other organisms and their environments. Mycologists may also study the medical and veterinary importance of fungi, including the diagnosis and treatment of fungal infections, as well as the development of antifungal drugs and vaccines.

Intracranial hypertension is a medical condition characterized by an increased pressure within the skull (intracranial space) that contains the brain, cerebrospinal fluid (CSF), and blood. Normally, the pressure inside the skull is carefully regulated to maintain a balance between the formation and absorption of CSF. However, when the production of CSF exceeds its absorption or when there is an obstruction in the flow of CSF, the pressure inside the skull can rise, leading to intracranial hypertension.

The symptoms of intracranial hypertension may include severe headaches, nausea, vomiting, visual disturbances such as blurred vision or double vision, and papilledema (swelling of the optic nerve disc). In some cases, intracranial hypertension can lead to serious complications such as vision loss, brain herniation, and even death if left untreated.

Intracranial hypertension can be idiopathic, meaning that there is no identifiable cause, or secondary to other underlying medical conditions such as brain tumors, meningitis, hydrocephalus, or certain medications. The diagnosis of intracranial hypertension typically involves a combination of clinical evaluation, imaging studies (such as MRI or CT scans), and lumbar puncture to measure the pressure inside the skull and assess the CSF composition. Treatment options may include medications to reduce CSF production, surgery to relieve pressure on the brain, or shunting procedures to drain excess CSF from the intracranial space.

An immunocompromised host refers to an individual who has a weakened or impaired immune system, making them more susceptible to infections and decreased ability to fight off pathogens. This condition can be congenital (present at birth) or acquired (developed during one's lifetime).

Acquired immunocompromised states may result from various factors such as medical treatments (e.g., chemotherapy, radiation therapy, immunosuppressive drugs), infections (e.g., HIV/AIDS), chronic diseases (e.g., diabetes, malnutrition, liver disease), or aging.

Immunocompromised hosts are at a higher risk for developing severe and life-threatening infections due to their reduced immune response. Therefore, they require special consideration when it comes to prevention, diagnosis, and treatment of infectious diseases.

Hydrocephalus is a medical condition characterized by an abnormal accumulation of cerebrospinal fluid (CSF) within the brain, leading to an increase in intracranial pressure and potentially causing damage to the brain tissues. This excessive buildup of CSF can result from either overproduction or impaired absorption of the fluid, which typically causes the ventricles (fluid-filled spaces) inside the brain to expand and put pressure on surrounding brain structures.

The condition can be congenital, present at birth due to genetic factors or abnormalities during fetal development, or acquired later in life as a result of injuries, infections, tumors, or other disorders affecting the brain's ability to regulate CSF flow and absorption. Symptoms may vary depending on age, severity, and duration but often include headaches, vomiting, balance problems, vision issues, cognitive impairment, and changes in behavior or personality.

Treatment for hydrocephalus typically involves surgically implanting a shunt system that diverts the excess CSF from the brain to another part of the body where it can be absorbed, such as the abdominal cavity. In some cases, endoscopic third ventriculostomy (ETV) might be an alternative treatment option, creating a new pathway for CSF flow within the brain. Regular follow-ups with neurosurgeons and other healthcare professionals are essential to monitor the condition and make any necessary adjustments to the treatment plan.

Immunocompetence is the condition of having a properly functioning immune system that can effectively respond to the presence of foreign substances, such as pathogens (like bacteria, viruses, and parasites) and other potentially harmful agents. It involves the ability of the immune system to recognize, attack, and eliminate these foreign substances while also maintaining tolerance to self-tissues and promoting tissue repair.

Immunocompetence is essential for overall health and wellbeing, as it helps protect the body from infections and diseases. Factors that can affect immunocompetence include age, genetics, stress, nutrition, sleep, and certain medical conditions or treatments (like chemotherapy or immunosuppressive drugs) that can weaken the immune system.

HIV seronegativity is a term used to describe a person who has tested negative for HIV (Human Immunodeficiency Virus) antibodies in their blood. This means that the individual does not show evidence of current or past infection with HIV, which can cause AIDS (Acquired Immune Deficiency Syndrome). However, it's important to note that there is a window period after initial infection during which a person may test negative for HIV antibodies, even though they are indeed infected. This window period typically lasts between 2-6 weeks but can extend up to 3 months in some cases. Therefore, if someone believes they have been exposed to HIV, they should consider getting tested again after this window period has passed.

Ceftriaxone is a third-generation cephalosporin antibiotic, which is used to treat a wide range of bacterial infections. It works by inhibiting the synthesis of the bacterial cell wall. Ceftriaxone has a broad spectrum of activity and is effective against many gram-positive and gram-negative bacteria, including some that are resistant to other antibiotics.

Ceftriaxone is available in injectable form and is commonly used to treat serious infections such as meningitis, pneumonia, and sepsis. It is also used to prevent infections after surgery or trauma. The drug is generally well-tolerated, but it can cause side effects such as diarrhea, nausea, vomiting, and rash. In rare cases, it may cause serious side effects such as anaphylaxis, kidney damage, and seizures.

It's important to note that Ceftriaxone should be used only under the supervision of a healthcare professional, and that it is not recommended for use in individuals with a history of allergic reactions to cephalosporins or penicillins. Additionally, as with all antibiotics, it should be taken as directed and for the full duration of the prescribed course of treatment, even if symptoms improve before the treatment is finished.

T-lymphocytopenia, idiopathic CD4-positive, also known as Idiopathic CD4 Lymphopenia (ICL), is a rare medical condition characterized by a significant decrease in the number of CD4+ T lymphocytes in the peripheral blood without an identifiable cause. CD4+ T cells are crucial for immune function and protection against certain types of infections, particularly those caused by viruses such as HIV.

ICL is typically defined as a CD4+ T-lymphocyte count below 300 cells/μL in the absence of HIV infection or any other known immunodeficiency disorder. The exact cause of ICL remains unknown, although it has been associated with genetic factors and autoimmune disorders.

People with ICL may be at increased risk for certain types of infections, such as opportunistic infections, which can occur when the immune system is weakened. However, the severity and frequency of infections in individuals with ICL are generally less than those seen in people with HIV-associated CD4 lymphopenia.

Regular monitoring of CD4+ T-lymphocyte counts and appropriate management of any infections that occur are important for people with ICL to maintain their overall health and well-being.

A CD4 lymphocyte count is a laboratory test that measures the number of CD4 T-cells (also known as CD4+ T-cells or helper T-cells) in a sample of blood. CD4 cells are a type of white blood cell that plays a crucial role in the body's immune response, particularly in fighting off infections caused by viruses and other pathogens.

CD4 cells express a protein on their surface called the CD4 receptor, which is used by human immunodeficiency virus (HIV) to infect and destroy these cells. As a result, people with HIV infection or AIDS often have low CD4 lymphocyte counts, which can make them more susceptible to opportunistic infections and other complications.

A normal CD4 lymphocyte count ranges from 500 to 1,200 cells per cubic millimeter of blood (cells/mm3) in healthy adults. A lower than normal CD4 count is often used as a marker for the progression of HIV infection and the development of AIDS. CD4 counts are typically monitored over time to assess the effectiveness of antiretroviral therapy (ART) and to guide clinical decision-making regarding the need for additional interventions, such as prophylaxis against opportunistic infections.

Acquired Immunodeficiency Syndrome (AIDS) is a chronic, life-threatening condition caused by the Human Immunodeficiency Virus (HIV). AIDS is the most advanced stage of HIV infection, characterized by the significant weakening of the immune system, making the person more susceptible to various opportunistic infections and cancers.

The medical definition of AIDS includes specific criteria based on CD4+ T-cell count or the presence of certain opportunistic infections and diseases. According to the Centers for Disease Control and Prevention (CDC), a person with HIV is diagnosed with AIDS when:

1. The CD4+ T-cell count falls below 200 cells per cubic millimeter of blood (mm3) - a normal range is typically between 500 and 1,600 cells/mm3.
2. They develop one or more opportunistic infections or cancers that are indicative of advanced HIV disease, regardless of their CD4+ T-cell count.

Some examples of these opportunistic infections and cancers include:

* Pneumocystis pneumonia (PCP)
* Candidiasis (thrush) affecting the esophagus, trachea, or lungs
* Cryptococcal meningitis
* Toxoplasmosis of the brain
* Cytomegalovirus disease
* Kaposi's sarcoma
* Non-Hodgkin's lymphoma
* Invasive cervical cancer

It is important to note that with appropriate antiretroviral therapy (ART), people living with HIV can maintain their CD4+ T-cell counts, suppress viral replication, and prevent the progression to AIDS. Early diagnosis and consistent treatment are crucial for managing HIV and improving life expectancy and quality of life.

Lymphadenitis is a medical term that refers to the inflammation of one or more lymph nodes, which are small, bean-shaped glands that are part of the body's immune system. Lymph nodes contain white blood cells called lymphocytes, which help fight infection and disease.

Lymphadenitis can occur as a result of an infection in the area near the affected lymph node or as a result of a systemic infection that has spread through the bloodstream. The inflammation causes the lymph node to become swollen, tender, and sometimes painful to the touch.

The symptoms of lymphadenitis may include fever, fatigue, and redness or warmth in the area around the affected lymph node. In some cases, the overlying skin may also appear red and inflamed. Lymphadenitis can occur in any part of the body where there are lymph nodes, including the neck, armpits, groin, and abdomen.

The underlying cause of lymphadenitis must be diagnosed and treated promptly to prevent complications such as the spread of infection or the formation of an abscess. Treatment may include antibiotics, pain relievers, and warm compresses to help reduce swelling and discomfort.

A "colony count" is a method used to estimate the number of viable microorganisms, such as bacteria or fungi, in a sample. In this technique, a known volume of the sample is spread onto the surface of a solid nutrient medium in a petri dish and then incubated under conditions that allow the microorganisms to grow and form visible colonies. Each colony that grows on the plate represents an individual cell (or small cluster of cells) from the original sample that was able to divide and grow under the given conditions. By counting the number of colonies that form, researchers can make a rough estimate of the concentration of microorganisms in the original sample.

The term "microbial" simply refers to microscopic organisms, such as bacteria, fungi, or viruses. Therefore, a "colony count, microbial" is a general term that encompasses the use of colony counting techniques to estimate the number of any type of microorganism in a sample.

Colony counts are used in various fields, including medical research, food safety testing, and environmental monitoring, to assess the levels of contamination or the effectiveness of disinfection procedures. However, it is important to note that colony counts may not always provide an accurate measure of the total number of microorganisms present in a sample, as some cells may be injured or unable to grow under the conditions used for counting. Additionally, some microorganisms may form clusters or chains that can appear as single colonies, leading to an overestimation of the true cell count.

Intracranial pressure (ICP) is the pressure inside the skull and is typically measured in millimeters of mercury (mmHg). It's the measurement of the pressure exerted by the cerebrospinal fluid (CSF), blood, and brain tissue within the confined space of the skull.

Normal ICP ranges from 5 to 15 mmHg in adults when lying down. Intracranial pressure may increase due to various reasons such as bleeding in the brain, swelling of the brain, increased production or decreased absorption of CSF, and brain tumors. Elevated ICP is a serious medical emergency that can lead to brain damage or even death if not promptly treated. Symptoms of high ICP may include severe headache, vomiting, altered consciousness, and visual changes.

Cerebrospinal fluid (CSF) proteins refer to the proteins present in the cerebrospinal fluid, which is a clear, colorless fluid that surrounds and protects the brain and spinal cord. The protein concentration in the CSF is much lower than that in the blood, and it contains a specific set of proteins that are produced by the brain, spinal cord, and associated tissues.

The normal range for CSF protein levels is typically between 15-45 mg/dL, although this can vary slightly depending on the laboratory's reference range. An elevation in CSF protein levels may indicate the presence of neurological disorders such as meningitis, encephalitis, multiple sclerosis, or Guillain-Barre syndrome. Additionally, certain conditions such as spinal cord injury, brain tumors, or neurodegenerative diseases can also cause an increase in CSF protein levels.

Therefore, measuring CSF protein levels is an important diagnostic tool for neurologists to evaluate various neurological disorders and monitor disease progression. However, it's essential to interpret the results of CSF protein tests in conjunction with other clinical findings and laboratory test results to make an accurate diagnosis.

I'm sorry for any confusion, but "South Africa" is not a medical term or concept. It is a country located at the southernmost tip of the African continent. If you have any questions related to medical topics, I would be happy to help answer them!

A fatal outcome is a term used in medical context to describe a situation where a disease, injury, or illness results in the death of an individual. It is the most severe and unfortunate possible outcome of any medical condition, and is often used as a measure of the severity and prognosis of various diseases and injuries. In clinical trials and research, fatal outcome may be used as an endpoint to evaluate the effectiveness and safety of different treatments or interventions.

"CBA" is an abbreviation for a specific strain of inbred mice that were developed at the Cancer Research Institute in London. The "Inbred CBA" mice are genetically identical individuals within the same strain, due to many generations of brother-sister matings. This results in a homozygous population, making them valuable tools for research because they reduce variability and increase reproducibility in experimental outcomes.

The CBA strain is known for its susceptibility to certain diseases, such as autoimmune disorders and cancer, which makes it a popular choice for researchers studying those conditions. Additionally, the CBA strain has been widely used in studies related to transplantation immunology, infectious diseases, and genetic research.

It's important to note that while "Inbred CBA" mice are a well-established and useful tool in biomedical research, they represent only one of many inbred strains available for scientific investigation. Each strain has its own unique characteristics and advantages, depending on the specific research question being asked.

Opportunistic infections (OIs) are infections that occur more frequently or are more severe in individuals with weakened immune systems, often due to a underlying condition such as HIV/AIDS, cancer, or organ transplantation. These infections are caused by microorganisms that do not normally cause disease in people with healthy immune function, but can take advantage of an opportunity to infect and cause damage when the body's defense mechanisms are compromised. Examples of opportunistic infections include Pneumocystis pneumonia, tuberculosis, candidiasis (thrush), and cytomegalovirus infection. Preventive measures, such as antimicrobial medications and vaccinations, play a crucial role in reducing the risk of opportunistic infections in individuals with weakened immune systems.

I'm sorry for any confusion, but "Niger" is not a medical term. It is the name of a country located in West Africa, officially known as the Republic of Niger. If you have any questions about medical terminology or health-related topics, please provide more details and I would be happy to help.

A Ventriculoperitoneal (VP) shunt is a surgical procedure that involves the insertion of a long, flexible tube (shunt) into the cerebral ventricles of the brain to drain excess cerebrospinal fluid (CSF). The other end of the shunt is directed into the peritoneal cavity, where the CSF can be absorbed.

The VP shunt is typically used to treat hydrocephalus, a condition characterized by an abnormal accumulation of CSF within the ventricles of the brain, which can cause increased intracranial pressure and damage to the brain. By diverting the excess CSF from the ventricles into the peritoneal cavity, the VP shunt helps to relieve the symptoms of hydrocephalus and prevent further neurological damage.

The shunt system consists of several components, including a ventricular catheter that is placed in the ventricle, a one-way valve that regulates the flow of CSF, and a distal catheter that is directed into the peritoneal cavity. The valve helps to prevent backflow of CSF into the brain and ensures that the fluid flows in only one direction, from the ventricles to the peritoneal cavity.

VP shunts are generally safe and effective, but they can be associated with complications such as infection, obstruction, or malfunction of the shunt system. Regular follow-up with a healthcare provider is necessary to monitor the function of the shunt and ensure that any potential issues are addressed promptly.

Combination drug therapy is a treatment approach that involves the use of multiple medications with different mechanisms of action to achieve better therapeutic outcomes. This approach is often used in the management of complex medical conditions such as cancer, HIV/AIDS, and cardiovascular diseases. The goal of combination drug therapy is to improve efficacy, reduce the risk of drug resistance, decrease the likelihood of adverse effects, and enhance the overall quality of life for patients.

In combining drugs, healthcare providers aim to target various pathways involved in the disease process, which may help to:

1. Increase the effectiveness of treatment by attacking the disease from multiple angles.
2. Decrease the dosage of individual medications, reducing the risk and severity of side effects.
3. Slow down or prevent the development of drug resistance, a common problem in chronic diseases like HIV/AIDS and cancer.
4. Improve patient compliance by simplifying dosing schedules and reducing pill burden.

Examples of combination drug therapy include:

1. Antiretroviral therapy (ART) for HIV treatment, which typically involves three or more drugs from different classes to suppress viral replication and prevent the development of drug resistance.
2. Chemotherapy regimens for cancer treatment, where multiple cytotoxic agents are used to target various stages of the cell cycle and reduce the likelihood of tumor cells developing resistance.
3. Cardiovascular disease management, which may involve combining medications such as angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, diuretics, and statins to control blood pressure, heart rate, fluid balance, and cholesterol levels.
4. Treatment of tuberculosis, which often involves a combination of several antibiotics to target different aspects of the bacterial life cycle and prevent the development of drug-resistant strains.

When prescribing combination drug therapy, healthcare providers must carefully consider factors such as potential drug interactions, dosing schedules, adverse effects, and contraindications to ensure safe and effective treatment. Regular monitoring of patients is essential to assess treatment response, manage side effects, and adjust the treatment plan as needed.

Mycological typing techniques are methods used to identify and classify fungi at the species or strain level, based on their unique biological characteristics. These techniques are often used in clinical laboratories to help diagnose fungal infections and determine the most effective treatment approaches.

There are several different mycological typing techniques that may be used, depending on the specific type of fungus being identified and the resources available in the laboratory. Some common methods include:

1. Phenotypic methods: These methods involve observing and measuring the physical characteristics of fungi, such as their growth patterns, colonial morphology, and microscopic features. Examples include macroscopic and microscopic examination, as well as biochemical tests to identify specific metabolic properties.

2. Genotypic methods: These methods involve analyzing the DNA or RNA of fungi to identify unique genetic sequences that can be used to distinguish between different species or strains. Examples include PCR-based methods, such as restriction fragment length polymorphism (RFLP) analysis and amplified fragment length polymorphism (AFLP) analysis, as well as sequencing-based methods, such as internal transcribed spacer (ITS) sequencing and multilocus sequence typing (MLST).

3. Proteotypic methods: These methods involve analyzing the proteins expressed by fungi to identify unique protein profiles that can be used to distinguish between different species or strains. Examples include matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and liquid chromatography-mass spectrometry (LC-MS).

Mycological typing techniques are important tools for understanding the epidemiology of fungal infections, tracking outbreaks, and developing effective treatment strategies. By accurately identifying the specific fungi causing an infection, healthcare providers can tailor their treatments to target the most vulnerable aspects of the pathogen, improving patient outcomes and reducing the risk of drug resistance.

Streptococcal infections are a type of infection caused by group A Streptococcus bacteria (Streptococcus pyogenes). These bacteria can cause a variety of illnesses, ranging from mild skin infections to serious and potentially life-threatening conditions such as sepsis, pneumonia, and necrotizing fasciitis (flesh-eating disease).

Some common types of streptococcal infections include:

* Streptococcal pharyngitis (strep throat) - an infection of the throat and tonsils that can cause sore throat, fever, and swollen lymph nodes.
* Impetigo - a highly contagious skin infection that causes sores or blisters on the skin.
* Cellulitis - a bacterial infection of the deeper layers of the skin and underlying tissue that can cause redness, swelling, pain, and warmth in the affected area.
* Scarlet fever - a streptococcal infection that causes a bright red rash on the body, high fever, and sore throat.
* Necrotizing fasciitis - a rare but serious bacterial infection that can cause tissue death and destruction of the muscles and fascia (the tissue that covers the muscles).

Treatment for streptococcal infections typically involves antibiotics to kill the bacteria causing the infection. It is important to seek medical attention if you suspect a streptococcal infection, as prompt treatment can help prevent serious complications.

The meninges are the protective membranes that cover the brain and spinal cord. They consist of three layers: the dura mater (the outermost, toughest layer), the arachnoid mater (middle layer), and the pia mater (the innermost, delicate layer). These membranes provide protection and support to the central nervous system, and contain blood vessels that supply nutrients and remove waste products. Inflammation or infection of the meninges is called meningitis, which can be a serious medical condition requiring prompt treatment.

Deoxycholic acid is a bile acid, which is a natural molecule produced in the liver and released into the intestine to aid in the digestion of fats. It is also a secondary bile acid, meaning that it is formed from the metabolism of primary bile acids by bacteria in the gut.

Deoxycholic acid has a chemical formula of C~24~H~39~NO~4~ and a molecular weight of 391.57 g/mol. It is a white crystalline powder that is soluble in water and alcohol. In the body, deoxycholic acid acts as a detergent to help break down dietary fats into smaller droplets, which can then be absorbed by the intestines.

In addition to its role in digestion, deoxycholic acid has been investigated for its potential therapeutic uses. For example, it is approved by the US Food and Drug Administration (FDA) as an injectable treatment for reducing fat in the submental area (the region below the chin), under the brand name Kybella. When injected into this area, deoxycholic acid causes the destruction of fat cells, which are then naturally eliminated from the body over time.

It's important to note that while deoxycholic acid is a natural component of the human body, its therapeutic use can have potential side effects and risks, so it should only be used under the supervision of a qualified healthcare professional.

Central nervous system (CNS) diseases refer to medical conditions that primarily affect the brain and spinal cord. The CNS is responsible for controlling various functions in the body, including movement, sensation, cognition, and behavior. Therefore, diseases of the CNS can have significant impacts on a person's quality of life and overall health.

There are many different types of CNS diseases, including:

1. Infectious diseases: These are caused by viruses, bacteria, fungi, or parasites that infect the brain or spinal cord. Examples include meningitis, encephalitis, and polio.
2. Neurodegenerative diseases: These are characterized by progressive loss of nerve cells in the brain or spinal cord. Examples include Alzheimer's disease, Parkinson's disease, and Huntington's disease.
3. Structural diseases: These involve damage to the physical structure of the brain or spinal cord, such as from trauma, tumors, or stroke.
4. Functional diseases: These affect the function of the nervous system without obvious structural damage, such as multiple sclerosis and epilepsy.
5. Genetic disorders: Some CNS diseases are caused by genetic mutations, such as spinal muscular atrophy and Friedreich's ataxia.

Symptoms of CNS diseases can vary widely depending on the specific condition and the area of the brain or spinal cord that is affected. They may include muscle weakness, paralysis, seizures, loss of sensation, difficulty with coordination and balance, confusion, memory loss, changes in behavior or mood, and pain. Treatment for CNS diseases depends on the specific condition and may involve medications, surgery, rehabilitation therapy, or a combination of these approaches.

Central nervous system (CNS) infections refer to infectious processes that affect the brain, spinal cord, and their surrounding membranes, known as meninges. These infections can be caused by various microorganisms, including bacteria, viruses, fungi, and parasites. Examples of CNS infections are:

1. Meningitis: Inflammation of the meninges, usually caused by bacterial or viral infections. Bacterial meningitis is a medical emergency that requires immediate treatment.
2. Encephalitis: Inflammation of the brain parenchyma, often caused by viral infections. Some viruses associated with encephalitis include herpes simplex virus, enteroviruses, and arboviruses.
3. Meningoencephalitis: A combined inflammation of both the brain and meninges, commonly seen in certain viral infections or when bacterial pathogens directly invade the brain.
4. Brain abscess: A localized collection of pus within the brain caused by a bacterial or fungal infection.
5. Spinal epidural abscess: An infection in the space surrounding the spinal cord, usually caused by bacteria.
6. Myelitis: Inflammation of the spinal cord, which can result from viral, bacterial, or fungal infections.
7. Rarely, parasitic infections like toxoplasmosis and cysticercosis can also affect the CNS.

Symptoms of CNS infections may include fever, headache, stiff neck, altered mental status, seizures, focal neurological deficits, or meningeal signs (e.g., Brudzinski's and Kernig's signs). The specific symptoms depend on the location and extent of the infection, as well as the causative organism. Prompt diagnosis and treatment are crucial to prevent long-term neurological complications or death.

Delayed hypersensitivity, also known as type IV hypersensitivity, is a type of immune response that takes place several hours to days after exposure to an antigen. It is characterized by the activation of T cells (a type of white blood cell) and the release of various chemical mediators, leading to inflammation and tissue damage. This reaction is typically associated with chronic inflammatory diseases, such as contact dermatitis, granulomatous disorders (e.g. tuberculosis), and certain autoimmune diseases.

The reaction process involves the following steps:

1. Sensitization: The first time an individual is exposed to an antigen, T cells are activated and become sensitized to it. This process can take several days.
2. Memory: Some of the activated T cells differentiate into memory T cells, which remain in the body and are ready to respond quickly if the same antigen is encountered again.
3. Effector phase: Upon subsequent exposure to the antigen, the memory T cells become activated and release cytokines, which recruit other immune cells (e.g. macrophages) to the site of inflammation. These cells cause tissue damage through various mechanisms, such as phagocytosis, degranulation, and the release of reactive oxygen species.
4. Chronic inflammation: The ongoing immune response can lead to chronic inflammation, which may result in tissue destruction and fibrosis (scarring).

Examples of conditions associated with delayed hypersensitivity include:

* Contact dermatitis (e.g. poison ivy, nickel allergy)
* Tuberculosis
* Leprosy
* Sarcoidosis
* Rheumatoid arthritis
* Type 1 diabetes mellitus
* Multiple sclerosis
* Inflammatory bowel disease (e.g. Crohn's disease, ulcerative colitis)

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Neisseria meningitidis, Serogroup A is a subtype of the bacterium Neisseria meningitidis, also known as meningococcus. This bacterium can cause serious infections such as meningitis (inflammation of the lining surrounding the brain and spinal cord) and septicemia (bloodstream infection).

The serogroup A designation refers to the antigenic structure of the polysaccharide capsule that surrounds the bacterium. There are several serogroups of Neisseria meningitidis, including A, B, C, Y, and W. Each serogroup has a distinct polysaccharide capsule, which can be identified using specific antibodies.

Serogroup A Neisseria meningitidis is a significant cause of epidemic meningitis, particularly in the "meningitis belt" of sub-Saharan Africa. Vaccines are available to protect against serogroup A meningococcal disease, and mass vaccination campaigns have been successful in reducing the incidence of epidemics in this region.

Microbial sensitivity tests, also known as antibiotic susceptibility tests (ASTs) or bacterial susceptibility tests, are laboratory procedures used to determine the effectiveness of various antimicrobial agents against specific microorganisms isolated from a patient's infection. These tests help healthcare providers identify which antibiotics will be most effective in treating an infection and which ones should be avoided due to resistance. The results of these tests can guide appropriate antibiotic therapy, minimize the potential for antibiotic resistance, improve clinical outcomes, and reduce unnecessary side effects or toxicity from ineffective antimicrobials.

There are several methods for performing microbial sensitivity tests, including:

1. Disk diffusion method (Kirby-Bauer test): A standardized paper disk containing a predetermined amount of an antibiotic is placed on an agar plate that has been inoculated with the isolated microorganism. After incubation, the zone of inhibition around the disk is measured to determine the susceptibility or resistance of the organism to that particular antibiotic.
2. Broth dilution method: A series of tubes or wells containing decreasing concentrations of an antimicrobial agent are inoculated with a standardized microbial suspension. After incubation, the minimum inhibitory concentration (MIC) is determined by observing the lowest concentration of the antibiotic that prevents visible growth of the organism.
3. Automated systems: These use sophisticated technology to perform both disk diffusion and broth dilution methods automatically, providing rapid and accurate results for a wide range of microorganisms and antimicrobial agents.

The interpretation of microbial sensitivity test results should be done cautiously, considering factors such as the site of infection, pharmacokinetics and pharmacodynamics of the antibiotic, potential toxicity, and local resistance patterns. Regular monitoring of susceptibility patterns and ongoing antimicrobial stewardship programs are essential to ensure optimal use of these tests and to minimize the development of antibiotic resistance.

Phagocytosis is the process by which certain cells in the body, known as phagocytes, engulf and destroy foreign particles, bacteria, or dead cells. This mechanism plays a crucial role in the immune system's response to infection and inflammation. Phagocytes, such as neutrophils, monocytes, and macrophages, have receptors on their surface that recognize and bind to specific molecules (known as antigens) on the target particles or microorganisms.

Once attached, the phagocyte extends pseudopodia (cell extensions) around the particle, forming a vesicle called a phagosome that completely encloses it. The phagosome then fuses with a lysosome, an intracellular organelle containing digestive enzymes and other chemicals. This fusion results in the formation of a phagolysosome, where the engulfed particle is broken down by the action of these enzymes, neutralizing its harmful effects and allowing for the removal of cellular debris or pathogens.

Phagocytosis not only serves as a crucial defense mechanism against infections but also contributes to tissue homeostasis by removing dead cells and debris.

The brain is the central organ of the nervous system, responsible for receiving and processing sensory information, regulating vital functions, and controlling behavior, movement, and cognition. It is divided into several distinct regions, each with specific functions:

1. Cerebrum: The largest part of the brain, responsible for higher cognitive functions such as thinking, learning, memory, language, and perception. It is divided into two hemispheres, each controlling the opposite side of the body.
2. Cerebellum: Located at the back of the brain, it is responsible for coordinating muscle movements, maintaining balance, and fine-tuning motor skills.
3. Brainstem: Connects the cerebrum and cerebellum to the spinal cord, controlling vital functions such as breathing, heart rate, and blood pressure. It also serves as a relay center for sensory information and motor commands between the brain and the rest of the body.
4. Diencephalon: A region that includes the thalamus (a major sensory relay station) and hypothalamus (regulates hormones, temperature, hunger, thirst, and sleep).
5. Limbic system: A group of structures involved in emotional processing, memory formation, and motivation, including the hippocampus, amygdala, and cingulate gyrus.

The brain is composed of billions of interconnected neurons that communicate through electrical and chemical signals. It is protected by the skull and surrounded by three layers of membranes called meninges, as well as cerebrospinal fluid that provides cushioning and nutrients.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

Antiretroviral Therapy, Highly Active (HAART) is a medical treatment regimen used to manage HIV infection. It involves the combination of three or more antiretroviral drugs from at least two different classes, aiming to maximally suppress viral replication and prevent the development of drug resistance. The goal of HAART is to reduce the amount of HIV in the body to undetectable levels, preserve immune function, and improve quality of life for people living with HIV. Commonly used antiretroviral classes include nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), integrase strand transfer inhibitors (INSTIs), and fusion inhibitors.

Virulence, in the context of medicine and microbiology, refers to the degree or severity of damage or harm that a pathogen (like a bacterium, virus, fungus, or parasite) can cause to its host. It is often associated with the ability of the pathogen to invade and damage host tissues, evade or suppress the host's immune response, replicate within the host, and spread between hosts.

Virulence factors are the specific components or mechanisms that contribute to a pathogen's virulence, such as toxins, enzymes, adhesins, and capsules. These factors enable the pathogen to establish an infection, cause tissue damage, and facilitate its transmission between hosts. The overall virulence of a pathogen can be influenced by various factors, including host susceptibility, environmental conditions, and the specific strain or species of the pathogen.

Mycoses are a group of diseases caused by fungal infections. These infections can affect various parts of the body, including the skin, nails, hair, lungs, and internal organs. The severity of mycoses can range from superficial, mild infections to systemic, life-threatening conditions, depending on the type of fungus and the immune status of the infected individual. Some common types of mycoses include candidiasis, dermatophytosis, histoplasmosis, coccidioidomycosis, and aspergillosis. Treatment typically involves antifungal medications, which can be topical or systemic, depending on the location and severity of the infection.

Pronase is not a medical term itself, but it is a proteolytic enzyme mixture derived from the bacterium Streptomyces griseus. The term "pronase" refers to a group of enzymes that can break down proteins into smaller peptides and individual amino acids by hydrolyzing their peptide bonds.

Pronase is used in various laboratory applications, including protein degradation, DNA and RNA isolation, and the removal of contaminating proteins from nucleic acid samples. It has also been used in some medical research contexts to study protein function and structure, as well as in certain therapeutic settings for its ability to break down proteins.

It is important to note that pronase is not a drug or a medical treatment itself but rather a laboratory reagent with potential applications in medical research and diagnostics.

Dermatomycoses are a group of fungal infections that affect the skin, hair, and nails. These infections are caused by various types of fungi, including dermatophytes, yeasts, and molds. Dermatophyte infections, also known as tinea, are the most common type of dermatomycoses and can affect different areas of the body, such as the scalp (tinea capitis), beard (tinea barbae), body (tinea corporis), feet (tinea pedis or athlete's foot), hands (tinea manuum), and nails (tinea unguium or onychomycosis). Yeast infections, such as those caused by Candida albicans, can lead to conditions like candidal intertrigo, vulvovaginitis, and balanitis. Mold infections are less common but can cause skin disorders like scalded skin syndrome and phaeohyphomycosis. Dermatomycoses are typically treated with topical or oral antifungal medications.

Haemophilus influenzae is a gram-negative, coccobacillary bacterium that can cause a variety of infectious diseases in humans. It is part of the normal respiratory flora but can become pathogenic under certain circumstances. The bacteria are named after their initial discovery in 1892 by Richard Pfeiffer during an influenza pandemic, although they are not the causative agent of influenza.

There are six main serotypes (a-f) based on the polysaccharide capsule surrounding the bacterium, with type b (Hib) being the most virulent and invasive. Hib can cause severe invasive diseases such as meningitis, pneumonia, epiglottitis, and sepsis, particularly in children under 5 years of age. The introduction of the Hib conjugate vaccine has significantly reduced the incidence of these invasive diseases.

Non-typeable Haemophilus influenzae (NTHi) strains lack a capsule and are responsible for non-invasive respiratory tract infections, such as otitis media, sinusitis, and exacerbations of chronic obstructive pulmonary disease (COPD). NTHi can also cause invasive diseases but at lower frequency compared to Hib.

Proper diagnosis and antibiotic susceptibility testing are crucial for effective treatment, as Haemophilus influenzae strains may display resistance to certain antibiotics.

The Blood-Brain Barrier (BBB) is a highly specialized, selective interface between the central nervous system (CNS) and the circulating blood. It is formed by unique endothelial cells that line the brain's capillaries, along with tight junctions, astrocytic foot processes, and pericytes, which together restrict the passage of substances from the bloodstream into the CNS. This barrier serves to protect the brain from harmful agents and maintain a stable environment for proper neural function. However, it also poses a challenge in delivering therapeutics to the CNS, as most large and hydrophilic molecules cannot cross the BBB.

I'm sorry for any confusion, but "Malawi" is not a medical term. It is the name of a country located in southeastern Africa. If you have any questions about medical terminology or health-related topics, I would be happy to help with those!

Streptococcus agalactiae, also known as Group B Streptococcus (GBS), is a type of bacteria that commonly colonizes the gastrointestinal and genitourinary tracts of humans. It is Gram-positive, facultatively anaerobic, and forms chains when viewed under the microscope.

While S. agalactiae can be carried asymptomatically by many adults, it can cause serious infections in newborns, pregnant women, elderly individuals, and people with weakened immune systems. In newborns, GBS can lead to sepsis, pneumonia, and meningitis, which can result in long-term health complications or even be fatal if left untreated.

Pregnant women are often screened for GBS colonization during the third trimester of pregnancy, and those who test positive may receive intrapartum antibiotics to reduce the risk of transmission to their newborns during delivery.

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

Triazoles are a class of antifungal medications that have broad-spectrum activity against various fungi, including yeasts, molds, and dermatophytes. They work by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased permeability and disruption of fungal growth. Triazoles are commonly used in both systemic and topical formulations for the treatment of various fungal infections, such as candidiasis, aspergillosis, cryptococcosis, and dermatophytoses. Some examples of triazole antifungals include fluconazole, itraconazole, voriconazole, and posaconazole.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

A headache is defined as pain or discomfort in the head, scalp, or neck. It can be a symptom of various underlying conditions such as stress, sinus congestion, migraine, or more serious issues like meningitis or concussion. Headaches can vary in intensity, ranging from mild to severe, and may be accompanied by other symptoms such as nausea, vomiting, or sensitivity to light and sound. There are over 150 different types of headaches, including tension headaches, cluster headaches, and sinus headaches, each with their own specific characteristics and causes.

Itraconazole is an antifungal medication used to treat various fungal infections, including blastomycosis, histoplasmosis, aspergillosis, and candidiasis. It works by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes, thereby disrupting the integrity and function of these membranes. Itraconazole is available in oral and intravenous forms for systemic use and as a topical solution or cream for localized fungal infections.

Medical Definition:
Itraconazole (i-tra-KON-a-zole): A synthetic triazole antifungal agent used to treat various fungal infections, such as blastomycosis, histoplasmosis, aspergillosis, and candidiasis. It inhibits the synthesis of ergosterol, a critical component of fungal cell membranes, leading to disruption of their integrity and function. Itraconazole is available in oral (capsule and solution) and intravenous forms for systemic use and as a topical solution or cream for localized fungal infections.

I'm sorry for any confusion, but "Vietnam" is not a medical term. It is the name of a country located in Southeast Asia. If you have any questions about medical conditions or terminology, I would be happy to help clarify those for you.

Enterovirus infections are viral illnesses caused by enteroviruses, which are a type of picornavirus. These viruses commonly infect the gastrointestinal tract and can cause a variety of symptoms depending on the specific type of enterovirus and the age and overall health of the infected individual.

There are over 100 different types of enteroviruses, including polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses such as EV-D68 and EV-A71. Some enterovirus infections may be asymptomatic or cause only mild symptoms, while others can lead to more severe illnesses.

Common symptoms of enterovirus infections include fever, sore throat, runny nose, cough, muscle aches, and skin rashes. In some cases, enteroviruses can cause more serious complications such as meningitis (inflammation of the membranes surrounding the brain and spinal cord), encephalitis (inflammation of the brain), myocarditis (inflammation of the heart muscle), and paralysis.

Enterovirus infections are typically spread through close contact with an infected person, such as through respiratory droplets or fecal-oral transmission. They can also be spread through contaminated surfaces or objects. Preventive measures include good hygiene practices, such as washing hands frequently and avoiding close contact with sick individuals.

There are no specific antiviral treatments for enterovirus infections, and most cases resolve on their own within a few days to a week. However, severe cases may require hospitalization and supportive care, such as fluids and medication to manage symptoms. Prevention efforts include vaccination against poliovirus and surveillance for emerging enteroviruses.

Osteomyelitis is a medical condition characterized by an infection that involves the bone or the bone marrow. It can occur as a result of a variety of factors, including bacterial or fungal infections that spread to the bone from another part of the body, or direct infection of the bone through trauma or surgery.

The symptoms of osteomyelitis may include pain and tenderness in the affected area, fever, chills, fatigue, and difficulty moving the affected limb. In some cases, there may also be redness, swelling, and drainage from the infected area. The diagnosis of osteomyelitis typically involves imaging tests such as X-rays, CT scans, or MRI scans, as well as blood tests and cultures to identify the underlying cause of the infection.

Treatment for osteomyelitis usually involves a combination of antibiotics or antifungal medications to eliminate the infection, as well as pain management and possibly surgical debridement to remove infected tissue. In severe cases, hospitalization may be necessary to monitor and manage the condition.

I believe there may be some confusion in your question. "Rabbits" is a common name used to refer to the Lagomorpha species, particularly members of the family Leporidae. They are small mammals known for their long ears, strong legs, and quick reproduction.

However, if you're referring to "rabbits" in a medical context, there is a term called "rabbit syndrome," which is a rare movement disorder characterized by repetitive, involuntary movements of the fingers, resembling those of a rabbit chewing. It is also known as "finger-chewing chorea." This condition is usually associated with certain medications, particularly antipsychotics, and typically resolves when the medication is stopped or adjusted.

Chorioretinitis is a medical term that refers to the inflammation of the choroid and the retina, which are both important structures in the eye. The choroid is a layer of blood vessels that supplies oxygen and nutrients to the retina, while the retina is a light-sensitive tissue that converts light into electrical signals that are sent to the brain and interpreted as visual images.

Chorioretinitis can be caused by various infectious and non-infectious conditions, such as bacterial, viral, fungal, or parasitic infections, autoimmune diseases, or cancer. The symptoms of chorioretinitis may include decreased vision, floaters, blurry vision, sensitivity to light, and eye pain. Treatment for chorioretinitis depends on the underlying cause and may include antibiotics, antiviral medications, corticosteroids, or other immunosuppressive therapies. It is important to seek medical attention promptly if you experience any symptoms of chorioretinitis, as timely diagnosis and treatment can help prevent permanent vision loss.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

Opsonins are proteins found in the blood that help enhance the immune system's response to foreign substances, such as bacteria and viruses. They do this by coating the surface of these pathogens, making them more recognizable to immune cells like neutrophils and macrophages. This process, known as opsonization, facilitates the phagocytosis (engulfing and destroying) of the pathogen by these immune cells.

There are two main types of opsonins:

1. IgG antibodies: These are a type of antibody produced by the immune system in response to an infection. They bind to specific antigens on the surface of the pathogen, marking them for destruction by phagocytic cells.
2. Complement proteins: The complement system is a group of proteins that work together to help eliminate pathogens. When activated, the complement system can produce various proteins that act as opsonins, including C3b and C4b. These proteins bind to the surface of the pathogen, making it easier for phagocytic cells to recognize and destroy them.

In summary, opsonin proteins are crucial components of the immune system's response to infections, helping to mark foreign substances for destruction by immune cells like neutrophils and macrophages.

Serotyping is a laboratory technique used to classify microorganisms, such as bacteria and viruses, based on the specific antigens or proteins present on their surface. It involves treating the microorganism with different types of antibodies and observing which ones bind to its surface. Each distinct set of antigens corresponds to a specific serotype, allowing for precise identification and characterization of the microorganism. This technique is particularly useful in epidemiology, vaccine development, and infection control.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Microbiological techniques refer to the various methods and procedures used in the laboratory for the cultivation, identification, and analysis of microorganisms such as bacteria, fungi, viruses, and parasites. These techniques are essential in fields like medical microbiology, food microbiology, environmental microbiology, and industrial microbiology.

Some common microbiological techniques include:

1. Microbial culturing: This involves growing microorganisms on nutrient-rich media in Petri dishes or test tubes to allow them to multiply. Different types of media are used to culture different types of microorganisms.
2. Staining and microscopy: Various staining techniques, such as Gram stain, acid-fast stain, and methylene blue stain, are used to visualize and identify microorganisms under a microscope.
3. Biochemical testing: These tests involve the use of specific biochemical reactions to identify microorganisms based on their metabolic characteristics. Examples include the catalase test, oxidase test, and sugar fermentation tests.
4. Molecular techniques: These methods are used to identify microorganisms based on their genetic material. Examples include polymerase chain reaction (PCR), DNA sequencing, and gene probes.
5. Serological testing: This involves the use of antibodies or antigens to detect the presence of specific microorganisms in a sample. Examples include enzyme-linked immunosorbent assay (ELISA) and Western blotting.
6. Immunofluorescence: This technique uses fluorescent dyes to label antibodies or antigens, allowing for the visualization of microorganisms under a fluorescence microscope.
7. Electron microscopy: This method uses high-powered electron beams to produce detailed images of microorganisms, allowing for the identification and analysis of their structures.

These techniques are critical in diagnosing infectious diseases, monitoring food safety, assessing environmental quality, and developing new drugs and vaccines.

Sensitivity and specificity are statistical measures used to describe the performance of a diagnostic test or screening tool in identifying true positive and true negative results.

* Sensitivity refers to the proportion of people who have a particular condition (true positives) who are correctly identified by the test. It is also known as the "true positive rate" or "recall." A highly sensitive test will identify most or all of the people with the condition, but may also produce more false positives.
* Specificity refers to the proportion of people who do not have a particular condition (true negatives) who are correctly identified by the test. It is also known as the "true negative rate." A highly specific test will identify most or all of the people without the condition, but may also produce more false negatives.

In medical testing, both sensitivity and specificity are important considerations when evaluating a diagnostic test. High sensitivity is desirable for screening tests that aim to identify as many cases of a condition as possible, while high specificity is desirable for confirmatory tests that aim to rule out the condition in people who do not have it.

It's worth noting that sensitivity and specificity are often influenced by factors such as the prevalence of the condition in the population being tested, the threshold used to define a positive result, and the reliability and validity of the test itself. Therefore, it's important to consider these factors when interpreting the results of a diagnostic test.

Laccase is an enzyme (specifically, a type of oxidoreductase) that is widely distributed in plants, fungi, and bacteria. It catalyzes the oxidation of various phenolic compounds, including polyphenols, methoxy-substituted phenols, aromatic amines, and some inorganic ions, while reducing molecular oxygen to water. This enzyme plays a crucial role in lignin degradation, as well as in the detoxification of xenobiotic compounds and in the synthesis of various pigments and polymers. The medical relevance of laccase is linked to its potential applications in bioremediation, biofuel production, and biotechnology.

Haemophilus influenzae type b (Hib) is a bacterial subtype that can cause serious infections, particularly in children under 5 years of age. Although its name may be confusing, Hib is not the cause of influenza (the flu). It is defined medically as a gram-negative, coccobacillary bacterium that is a member of the family Pasteurellaceae.

Hib is responsible for several severe and potentially life-threatening infections such as meningitis (inflammation of the membranes surrounding the brain and spinal cord), epiglottitis (swelling of the tissue located at the base of the tongue that can block the windpipe), pneumonia, and bacteremia (bloodstream infection).

Before the introduction of the Hib vaccine in the 1980s and 1990s, Haemophilus influenzae type b was a leading cause of bacterial meningitis in children under 5 years old. Since then, the incidence of invasive Hib disease has decreased dramatically in vaccinated populations.

Septic abortion is a medical term used to describe a spontaneous abortion or miscarriage that is associated with infection. This occurs when the products of conception, such as the fetal tissue and placenta, are not completely expelled from the uterus, leading to an infection of the uterine lining and potentially the pelvic cavity.

The infection can cause fever, chills, severe abdominal pain, foul-smelling vaginal discharge, and heavy bleeding. If left untreated, septic abortion can lead to serious complications such as sepsis, infertility, and even death. It is important to seek medical attention immediately if you suspect a septic abortion. Treatment typically involves antibiotics to clear the infection and possibly surgical intervention to remove any remaining products of conception.

A "false positive reaction" in medical testing refers to a situation where a diagnostic test incorrectly indicates the presence of a specific condition or disease in an individual who does not actually have it. This occurs when the test results give a positive outcome, while the true health status of the person is negative or free from the condition being tested for.

False positive reactions can be caused by various factors including:

1. Presence of unrelated substances that interfere with the test result (e.g., cross-reactivity between similar molecules).
2. Low specificity of the test, which means it may detect other conditions or irrelevant factors as positive.
3. Contamination during sample collection, storage, or analysis.
4. Human errors in performing or interpreting the test results.

False positive reactions can have significant consequences, such as unnecessary treatments, anxiety, and increased healthcare costs. Therefore, it is essential to confirm any positive test result with additional tests or clinical evaluations before making a definitive diagnosis.

Enterovirus B, Human (HEVB) is a type of enterovirus that infects humans. Enteroviruses are small viruses that belong to the Picornaviridae family and are named after the Greek word "pico" meaning small. They are further classified into several species, including Human Enterovirus B (HEV-B).

HEVB includes several serotypes, such as Coxsackievirus A9, A16, and B types, and Echoviruses. These viruses are typically transmitted through the fecal-oral route or respiratory droplets and can cause a range of illnesses, from mild symptoms like fever, rash, and sore throat to more severe diseases such as meningitis, myocarditis, and paralysis.

HEVB infections are common worldwide, and people of all ages can be affected. However, young children and individuals with weakened immune systems are at higher risk for severe illness. Prevention measures include good hygiene practices, such as washing hands frequently and avoiding close contact with sick individuals. There is no specific treatment for HEVB infections, and most cases resolve on their own within a few days to a week. However, hospitalization may be necessary for severe cases.

Echovirus 9 is a type of enterovirus, which is a single-stranded RNA virus that can infect humans. The name "echovirus" stands for "enteric cytopathic human orphan virus," as these viruses were initially discovered in the intestines and were not known to cause any specific diseases. However, it is now known that some echoviruses, including echovirus 9, can cause a range of illnesses, particularly in children.

Echovirus 9 is transmitted through the fecal-oral route, usually through contaminated food or water. Once inside the body, the virus can infect various organs and tissues, including the respiratory system, central nervous system, and skin.

The symptoms of echovirus 9 infection can vary widely depending on the age and overall health of the infected person, as well as the severity of the infection. In some cases, people may not experience any symptoms at all. However, in others, the virus can cause a range of illnesses, including:

* Common cold-like symptoms, such as runny nose, sore throat, and cough
* Fever and fatigue
* Skin rashes or mouth ulcers
* Gastrointestinal symptoms, such as nausea, vomiting, diarrhea, and abdominal pain
* Neurological symptoms, such as meningitis, encephalitis, or paralysis

In severe cases, echovirus 9 infection can lead to serious complications, particularly in people with weakened immune systems. Treatment typically involves supportive care, such as fluids and medication to manage fever and pain. There is no specific antiviral treatment for echovirus 9 infection. Prevention measures include good hygiene practices, such as washing hands frequently and avoiding contact with sick individuals.

Meningeal carcinomatosis, also known as leptomeningeal metastasis or neoplastic meningitis, is a medical condition characterized by the spread of cancer cells to the meninges, which are the thin layers of tissue that cover and protect the brain and spinal cord.

In this condition, cancer cells from a primary tumor or metastatic cancer elsewhere in the body invade the cerebrospinal fluid (CSF) and spread throughout the meningeal spaces, causing inflammation and damage to the surrounding tissues. This can result in various neurological symptoms such as headache, nausea, vomiting, seizures, confusion, weakness, or paralysis, depending on the location of the cancer cells in the meninges.

Meningeal carcinomatosis is a serious and often life-threatening complication of advanced cancer, with a poor prognosis and limited treatment options. It can occur in various types of cancer, including lung, breast, melanoma, and hematological malignancies such as leukemia and lymphoma. Early diagnosis and prompt treatment are crucial to improve the quality of life and prolong survival in affected patients.

Streptococcus suis is a Gram-positive, beta-hemolytic streptococcus that is a significant pathogen in pig populations worldwide. It can cause a variety of clinical manifestations in pigs, including meningitis, arthritis, endocarditis, and septicemia. Transmission to humans can occur through contact with infected pigs or contaminated pork products, resulting in diseases such as meningitis, sepsis, endocarditis, and arthritis. There are 35 serotypes of S. suis, but only a few (including serotypes 1, 2, 4, 5, 9, 14, 16, 21, 24, and 31) are commonly associated with disease in pigs and humans.

Ampicillin is a penicillin-type antibiotic used to treat a wide range of bacterial infections. It works by interfering with the ability of bacteria to form cell walls, which are essential for their survival. This causes the bacterial cells to become unstable and eventually die.

The medical definition of Ampicillin is:

"A semi-synthetic penicillin antibiotic, derived from the Penicillium mold. It is used to treat a variety of infections caused by susceptible gram-positive and gram-negative bacteria. Ampicillin is effective against both aerobic and anaerobic organisms. It is commonly used to treat respiratory tract infections, urinary tract infections, meningitis, and endocarditis."

It's important to note that Ampicillin is not effective against infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or other bacteria that have developed resistance to penicillins. Additionally, overuse of antibiotics like Ampicillin can lead to the development of antibiotic resistance, which is a significant public health concern.

Leukocytosis is a condition characterized by an increased number of leukocytes (white blood cells) in the peripheral blood. A normal white blood cell count ranges from 4,500 to 11,000 cells per microliter of blood in adults. Leukocytosis is typically considered present when the white blood cell count exceeds 11,000 cells/µL. However, the definition might vary slightly depending on the laboratory and clinical context.

Leukocytosis can be a response to various underlying conditions, including bacterial or viral infections, inflammation, tissue damage, leukemia, and other hematological disorders. It is essential to investigate the cause of leukocytosis through further diagnostic tests, such as blood smears, differential counts, and additional laboratory and imaging studies, to guide appropriate treatment.

Bacterial polysaccharides are complex carbohydrates that consist of long chains of sugar molecules (monosaccharides) linked together by glycosidic bonds. They are produced and used by bacteria for various purposes such as:

1. Structural components: Bacterial polysaccharides, such as peptidoglycan and lipopolysaccharide (LPS), play a crucial role in maintaining the structural integrity of bacterial cells. Peptidoglycan is a major component of the bacterial cell wall, while LPS forms the outer layer of the outer membrane in gram-negative bacteria.
2. Nutrient storage: Some bacteria synthesize and store polysaccharides as an energy reserve, similar to how plants store starch. These polysaccharides can be broken down and utilized by the bacterium when needed.
3. Virulence factors: Bacterial polysaccharides can also function as virulence factors, contributing to the pathogenesis of bacterial infections. For example, certain bacteria produce capsular polysaccharides (CPS) that surround and protect the bacterial cells from host immune defenses, allowing them to evade phagocytosis and persist within the host.
4. Adhesins: Some polysaccharides act as adhesins, facilitating the attachment of bacteria to surfaces or host cells. This is important for biofilm formation, which helps bacteria resist environmental stresses and antibiotic treatments.
5. Antigenic properties: Bacterial polysaccharides can be highly antigenic, eliciting an immune response in the host. The antigenicity of these molecules can vary between different bacterial species or even strains within a species, making them useful as targets for vaccines and diagnostic tests.

In summary, bacterial polysaccharides are complex carbohydrates that serve various functions in bacteria, including structural support, nutrient storage, virulence factor production, adhesion, and antigenicity.

Fungal proteins are a type of protein that is specifically produced and present in fungi, which are a group of eukaryotic organisms that include microorganisms such as yeasts and molds. These proteins play various roles in the growth, development, and survival of fungi. They can be involved in the structure and function of fungal cells, metabolism, pathogenesis, and other cellular processes. Some fungal proteins can also have important implications for human health, both in terms of their potential use as therapeutic targets and as allergens or toxins that can cause disease.

Fungal proteins can be classified into different categories based on their functions, such as enzymes, structural proteins, signaling proteins, and toxins. Enzymes are proteins that catalyze chemical reactions in fungal cells, while structural proteins provide support and protection for the cell. Signaling proteins are involved in communication between cells and regulation of various cellular processes, and toxins are proteins that can cause harm to other organisms, including humans.

Understanding the structure and function of fungal proteins is important for developing new treatments for fungal infections, as well as for understanding the basic biology of fungi. Research on fungal proteins has led to the development of several antifungal drugs that target specific fungal enzymes or other proteins, providing effective treatment options for a range of fungal diseases. Additionally, further study of fungal proteins may reveal new targets for drug development and help improve our ability to diagnose and treat fungal infections.

Strongylida infections are a group of parasitic diseases caused by roundworms that belong to the order Strongylida. These nematodes infect various hosts, including humans, causing different clinical manifestations depending on the specific species involved. Here are some examples:

1. Strongyloidiasis: This is an infection caused by the nematode Strongyloides stercoralis. The parasite can penetrate the skin and migrate to the lungs and small intestine, causing respiratory and gastrointestinal symptoms such as cough, wheezing, abdominal pain, and diarrhea. In immunocompromised individuals, the infection can become severe and disseminated, leading to systemic illness and even death.
2. Hookworm infections: The hookworms Ancylostoma duodenale and Necator americanus infect humans through skin contact with contaminated soil. The larvae migrate to the lungs and then to the small intestine, where they attach to the intestinal wall and feed on blood. Heavy infections can cause anemia, protein loss, and developmental delays in children.
3. Trichostrongyliasis: This is a group of infections caused by various species of nematodes that infect the gastrointestinal tract of humans and animals. The parasites can cause symptoms such as abdominal pain, diarrhea, and anemia.
4. Toxocariasis: This is an infection caused by the roundworms Toxocara canis or Toxocara cati, which infect dogs and cats, respectively. Humans can become infected through accidental ingestion of contaminated soil or food. The larvae migrate to various organs such as the liver, lungs, and eyes, causing symptoms such as fever, cough, abdominal pain, and vision loss.

Preventive measures for Strongylida infections include personal hygiene, proper sanitation, and avoidance of contact with contaminated soil or water. Treatment usually involves antiparasitic drugs such as albendazole or ivermectin, depending on the specific infection and severity of symptoms.

The subarachnoid space is the area between the arachnoid mater and pia mater, which are two of the three membranes covering the brain and spinal cord (the third one being the dura mater). This space is filled with cerebrospinal fluid (CSF), which provides protection and cushioning to the central nervous system. The subarachnoid space also contains blood vessels that supply the brain and spinal cord with oxygen and nutrients. It's important to note that subarachnoid hemorrhage, a type of stroke, can occur when there is bleeding into this space.

A coma is a deep state of unconsciousness in which an individual cannot be awakened, cannot respond to stimuli, and does not exhibit any sleep-wake cycles. It is typically caused by severe brain injury, illness, or toxic exposure that impairs the function of the brainstem and cerebral cortex.

In a coma, the person may appear to be asleep, but they are not aware of their surroundings or able to communicate or respond to stimuli. Comas can last for varying lengths of time, from days to weeks or even months, and some people may emerge from a coma with varying degrees of brain function and disability.

Medical professionals use various diagnostic tools and assessments to evaluate the level of consciousness and brain function in individuals who are in a coma, including the Glasgow Coma Scale (GCS), which measures eye opening, verbal response, and motor response. Treatment for coma typically involves supportive care to maintain vital functions, manage any underlying medical conditions, and prevent further complications.

The most common fungal meningitis is cryptococcal meningitis due to Cryptococcus neoformans. In Africa, cryptococcal meningitis ... In 2010 it was estimated that meningitis resulted in 420,000 deaths, excluding cryptococcal meningitis. Bacterial meningitis ... Fungal meningitis, such as cryptococcal meningitis, is treated with long courses of high dose antifungals, such as amphotericin ... Meningitis may also result from various non-infectious causes. The term aseptic meningitis refers to cases of meningitis in ...
Meningitis Cryptococcal meningitis "Meningitis". Paediatrics & Child Health. 6 (3): 126-7. March 2001. doi:10.1093/pch/6.3.126 ... Fungal meningitis refers to meningitis caused by a fungal infection. Symptoms of fungal meningitis are generally similar to ... "Meningitis , Fungal Meningitis". www.cdc.gov. Retrieved 29 November 2017. Gottfredsson M, Perfect JR (2000). "Fungal meningitis ... Meningitis is an unusual manifestation of blastomycosis and can be very difficult to diagnose. Cryptococcus (Cryptococcal ...
which cause cryptococcal meningitis. In microscopy, India Ink is used to circle mounted specimens like diatoms or radiolarians ...
Dupont, B., & Drouhet, E. (1987). Cryptococcal meningitis and fluconazole. Annals of Internal Medicine, 106(5), 778-778. Dupont ...
Cryptococcal antigen from cerebrospinal fluid is thought to be the best test for diagnosis of cryptococcal meningitis in terms ... "The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis" (PDF). Journal of Clinical ... Cryptococcal meningitis should be treated for two weeks with intravenous amphotericin B 0.7-1.0 mg/kg/day and oral flucytosine ... If cryptococcal meningitis occurs, mortality rate is between 10 and 30%. Cryptococcosis that does not affect the central ...
Cochrane Infectious Diseases Group) (July 2018). "Treatment for HIV-associated cryptococcal meningitis". The Cochrane Database ... Because of this, respiratory and central nervous system opportunistic infections, including tuberculosis and meningitis, ... like meningitis. Histoplasma capsulatum is a species of fungus known to cause histoplasmosis, which can present with an array ...
Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis Outcomes of cryptococcal meningitis in Uganda ... "Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy". ... "Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis". New England Journal of Medicine. 370 (26): 2487- ... "Clinical Features and Serum Biomarkers in HIV Immune Reconstitution Inflammatory Syndrome after Cryptococcal Meningitis: A ...
... within weeks he was hospitalized with cryptosporidiosis and subsequently cryptococcal meningitis. At noon on August 15, 1984, ...
IRIS is particularly problematic in cryptococcal meningitis as IRIS is fairly common and can be fatal. IRIS has been described ... IRIS may be the cause of paradoxically worse outcomes for cryptococcal meningitis in immunocompetent compared with ... Important exceptions include cases of Cryptococcal-IRIS with worsening meningitis symptoms (cranial nerve defects, hearing or ... Important exceptions to using corticosteroids include Cryptococcal meningitis and Kaposi's sarcoma, as they have been ...
Around the same time, patients were more frequently suffering from Cryptococcal meningitis. Both diseases are opportunistic ...
In addition, she and her team discovered the novel antifungal agent, APX2039, for the treatment of cryptococcal meningitis. As ... It is currently in preclinical development for the treatment of cryptococcal meningitis. Shaw has over 100 published articles. ... a unique Gwt1 inhibitor that is in preclinical development for the treatment of cryptococcal meningitis. Shaw was born in ...
Rajasingham R, Rolfes MA, Birkenkamp KE, Meya DB, Boulware DR (25 September 2012). "Cryptococcal meningitis treatment ... Ghuneim, Nedal; Dheir, Majdi; Issawi, Fouad (December 2013). "Incidence and case-fatality rate of meningococcal meningitis and ...
Many of these patients displayed cryptococcal meningitis, which is often linked to AIDS. Kaptita, McCormick, and Piot, as well ...
Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy (2008 ... "Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral Therapy". ... Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS (1998), Severe ... "Combination Therapy with Fluconazole and Flucytosine for Cryptococcal Meningitis in Ugandan Patients with AIDS". Clinical ...
He died on 5 April 1986 at Parirenyatwa Hospital in Harare from cryptococcal meningitis. SW Radio Africa expressed doubt about ... Deaths from meningitis, Prisoners and detainees of Zimbabwe, Northern Ndebele people, Zimbabwean military leaders). ...
Chou, P.; Ouyang, W.; Lan, T. & Chan, C. (2015). "Secondary mania due to AIDS and cryptococcal meningitis in a 78-year-old ... The study stated that the exact link between the secondary mania and the enterococcal meningitis is unknown. Since its first ... Liang, C. & Yang, F. (May-June 2011). "Secondary mania associated with enterococcal meningitis in an elderly patient". General ... Eventually, she was diagnosed with enterococcal meningitis for her physical symptoms and secondary mania for her psychological ...
The most common illnesses that it treats are TB, diarrhoeal disease and Cryptococcal Meningitis. The EMMS funded in part the ...
"Expert consortium begins study in South Africa to develop an optimized treatment for cryptococcal meningitis , DNDi". dndi.org ... cryptococcal meningitis, hepatitis C, and dengue. DNDi's malaria activities were transferred to Medicines for Malaria Venture ( ...
Some of these among others include; Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly ... Kambugu, Andrew (2008). "Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active ... This study found significant cryptococcal meningitis associated mortality persists, despite the administration of amphotericin ... Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count ...
Boulware's primary research has been focused on improving the diagnosis, prevention, and treatment of cryptococcal meningitis. ... to study HIV/AIDS and cryptococcal meningitis with the Infectious Diseases Institute in Uganda. He was named to the Lois and ... "Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and ... prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children US Guidelines for the ...
It is considered first line therapy for invasive mucormycosis infections, cryptococcal meningitis, and certain aspergillus and ... February 2010). "Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious ...
Merry M, Boulware DR (June 2016). "Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine ... cryptococcal meningitis). The cytostatic cytarabine inhibits the antimycotic activity of flucytosine.[citation needed] Symptoms ...
Doctors were unable to diagnose the exact ailment and believed it was cryptococcal meningitis and tuberculosis of the brain. ...
Moreover, pulmonary cryptococcosis worsen the prognosis of cryptococcal meningitis. Cryptococcal meningitis (infection of the ... Cryptococcal antigen from cerebrospinal fluid is the best test for diagnosis of cryptococcal meningitis in terms of sensitivity ... for evidence of cryptococcal meningitis, even if they do not have signs or symptoms of CNS disease. Detection of cryptococcal ... some studies suggest a higher mortality rate in patients with non-HIV cryptococcal meningitis secondary to the role of T-cell ...
... he suddenly fell ill and was diagnosed with AIDS-related cryptococcal meningitis. He suffered from several infections and died ...
Bennett and Peter Richard Williamson are studying previously healthy patients with cryptococcal meningitis to discover ...
... however treatment has been successful for cryptococcal and coccidioidal meningitis". It is also prescribed for systemic ... Therefore, it should not be used to treat meningitis or other central nervous system infections. According to the Johns Hopkins ...
Cryptococcal disease is an uncommon disease that can affect the lungs (pneumonia) and nervous system (causing meningitis and ... Cryptococcal antigen testing from serum or cerebrospinal fluid is a useful preliminary test for cryptococcal infection, and has ... A person with cryptococcal disease is not contagious. Most people who are exposed to the fungus do not become ill. In people ... Symptoms of cryptococcal disease include: Prolonged cough (lasting weeks or months) Sputum production Sharp chest pain ...
Lyme disease Syphilis Leptospirosis Fungi Cryptococcal infection Coccidioidal infection Drug-induced aseptic meningitis (DIAM) ... Viral meningitis Enterovirus (EV) caused meningitis. This is the most common cause of viral meningitis, with 90% of viral ... Symptoms of meningitis caused by an acute viral infection last between one and two weeks. When aseptic meningitis is caused by ... Aseptic meningitis cases have varied historically. Aseptic meningitis caused by mumps has declined in the United States due to ...
Thomas Svarney MedMerits Cryptococcal meningitis Historical note and nomenclature The Yeasts, a Taxonomic Study by C. P. ...
Cryptococcal meningitis is a fungal infection of the tissues covering the brain and spinal cord. These tissues are called ... Cryptococcal meningitis is a fungal infection of the tissues covering the brain and spinal cord. These tissues are called ... In most cases, cryptococcal meningitis is caused by the fungus Cryptococcus neoformans. This fungus is found in soil around the ... Cryptococcal meningitis is a fungal infection of the tissues covering the brain and spinal cord. These tissues are called ...
A new short-course treatment is effective against HIV-associated cryptococcal meningitis with fewer serious side effects, and ... Cryptococcal Meningitis, Fungal Infection, Healthcare, HIV, Hospital, Hygiene, Kidney, Laboratory, Medicine, Meningitis, ... says that cryptococcal meningitis is a severe disease in people with HIV, and is the most common cause of meningitis in adults ... New short-course treatment effective against HIV-associated cryptococcal meningitis. *Download PDF Copy ...
A large-scale clinical trial has demonstrated the efficacy of a new therapeutic protocol to treat cryptococcal meningitis ... Cryptococcal meningitis: a new effective treatment with fewer side effects. Cryptococcus neoformans in a brain abscess. ... Cryptococcal meningitis is a severe invasive fungal infection caused by a yeast. It occurs most often in severely ... HomeThe research journalNewsCryptococcal meningitis: a new effective treatment with fewer side effects ...
Cryptococcal Meningitis: Meningeal inflammation produced by CRYPTOCOCCUS NEOFORMANS, an encapsulated yeast that tends to infect ... Cryptococcal Meningitis. Subscribe to New Research on Cryptococcal Meningitis Meningeal inflammation produced by CRYPTOCOCCUS ... patients with cryptococcal meningitis - an urgent need.". 03/01/2012 - "Herein, we present a case of cryptococcal meningitis ... presented with cryptococcal meningitis. ". 03/01/2011 - "Early onset of paucisymptomatic cryptococcal meningitis in a kidney ...
Cryptococcal meningitis (CM) is a fungal infection of the tissues covering the brain and spinal cord. These tissues are called ... Meningitis. Meningitis is an infection of the membranes covering the brain and spinal cord. This covering is called the ... Fungal meningitis. CDC.gov Web site. Updated April 15, 2016. www.cdc.gov/meningitis/fungal.html . Accessed December 5, 2016. ... Meningitis can quickly become a life-threatening illness.. Call your local emergency number or go to an emergency room if you ...
... which strongly predicts the development of cryptococcal meningitis.. Cryptococcal meningitis can be treated with antifungal ... Cryptococcal meningitis may cause up to 15% of all HIV-related deaths each year in lower- and middle-income countries (181,000 ... All study participants had been diagnosed with a first episode of cryptococcal meningitis. The median CD4 cell count of study ... The findings open up the possibility of more widespread treatment for cryptococcal meningitis, one of the major causes of death ...
... in patients with cryptococcal meningitis.. Method. The sample included adults diagnosed with cryptococcal meningitis admitted ... More than half of the patients with cryptococcal meningitis (CM) exhibit ICH11 Graybill JR, Sobel J, Saag M, van Der Horst C, ... Management of cryptococcal meningitis with extremely high intracranial pressure in HIV-infected patients. Clin Infect Dis. 2004 ... Management of cryptococcal meningitis with extremely high intracranial pressure in HIV-infected patients. Clin Infect Dis. 2004 ...
Affecting Mortality Among HIV Positive Patients Two Years after Completing Recommended Therapy for Cryptococcal Meningitis in ...
... associated cryptococcal meningitis in Thailand, we also compared the mycological efficacy, toxicity, and pharmacokinetics of ... Oral versus Intravenous Flucytosine in Patients with Human Immunodeficiency Virus-Associated Cryptococcal Meningitis ... Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar ... Oral versus Intravenous Flucytosine in Patients with Human Immunodeficiency Virus-Associated Cryptococcal Meningitis ...
Isavuconazole Is Effective for the Treatment of Experimental Cryptococcal Meningitis.. Nathan P Wiederhold, Laura Kovanda, ... We evaluated the efficacy of isavuconazole against cryptococcal meningitis. Treatment with either oral isavuconazole (120 mg/kg ...
... and Fungal Meningitis: Learn the Difference, Recurrent Meningitis: A Rare but Serious Condition, Understanding the Meningitis ... However, cryptococcal meningitis is still a major problem where HIV prevalence is high and where access to healthcare may be ... Cryptococcal meningitis specifically occurs after Cryptococcus has spread from the lungs to the brain. You can review and ... Introduction: Cryptococcal Meningitis (CM) remains a high-risk clinical condition, and many patients require emergency ...
... cryptococcal meningitis) answers are found in the Diagnosaurus powered by Unbound Medicine. Available for iPhone, iPad, Android ... Cryptococcosis (cryptococcal Meningitis) [Internet]. In: Diagnosaurus. McGraw-Hill Education; 2014. [cited 2023 December 08]. ... Zeiger, Roni F.. "Cryptococcosis (cryptococcal Meningitis)." Diagnosaurus, 4th ed., McGraw-Hill Education, 2014. Medicine ... TY - ELEC T1 - Cryptococcosis (cryptococcal meningitis) ID - 114805 A1 - Zeiger,Roni F, Y1 - 2014/12/01/ BT - Diagnosaurus UR ...
Tag Archives: Cryptococcal Meningitis Woman was blinded and nearly killed simply by coming into contact with pigeon feces.. ... a young New Brunswick woman contracted a potentially fatal condition known as Cryptococcal Meningitis. This is a serious fungal ...
Cryptococcosis and cryptococcal meningitis: New predictors and clinical outcomes at a United States academic medical centre ... Cryptococcosis and cryptococcal meningitis: New predictors and clinical outcomes at a United States academic medical centre ... An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis ... Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar ...
Cryptococcal Tuberculous Syphilitic Listeria species Lymphomatous Aseptic Chronic meningitis or episodes of acute meningitis ... Different forms of meningitis are associated with HIV infection. They may be classified as follows, according to the etiologic ... from cryptococcal meningitis, TB meningitis and pneumococcal meningitis, respectively. [4] In developed countries, cryptococcal ... Cryptococcal meningitis. In one study of patients with AIDS, 26% of patients with cryptococcal meningitis had normal CSF ...
Other causes of meningitis must be excluded in patient suspected to have cryptococcal meningitis &mdas; ... Serum and CSF cryptococcal antigen (CRAG) is an useful test to diagnose cryptococcal meningitis. It is both sensitive and ... Cryptococcal meningitis is a major cause of mortality in immunocompromised patients. The diagnosis of the condition requires a ... Lumbar puncture in cryptococcal meningitis. *Jameson, Fauci, Kasper, Hauser, Longo, Loscalzo. Harrisons Principles of Internal ...
Cryptococcal antigen tests were positive and Cryptococcus neoformans was cultured from the albumin-treated cerebrospinal fluid ... A pseudooutbreak of cryptococcal meningitis was caused by the use of contaminated albumin solution used in the preparation of ... Disseminated cryptococcal infection despite treatment for cryptococcal meningitis.. *Possibility of diagnosing meningitis by ... A pseudooutbreak of cryptococcal meningitis was caused by the use of contaminated albumin solution used in the preparation of ...
Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis: Ali A. ... Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis: Ali A. ... Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis: Ali A. ... Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis : Ali A ...
Independent Association between Rate of Clearance of Infection and Clinical Outcome of HIV‐Associated Cryptococcal Meningitis: ... Independent Association between Rate of Clearance of Infection and Clinical Outcome of HIV‐Associated Cryptococcal Meningitis: ...
The most common fungal meningitis is cryptococcal meningitis due to Cryptococcus neoformans. In Africa, cryptococcal meningitis ... In 2010 it was estimated that meningitis resulted in 420,000 deaths, excluding cryptococcal meningitis. Bacterial meningitis ... Fungal meningitis, such as cryptococcal meningitis, is treated with long courses of high dose antifungals, such as amphotericin ... Meningitis may also result from various non-infectious causes. The term aseptic meningitis refers to cases of meningitis in ...
Cryptococcal meningitis ( neoformansvar. gattii) leading to blindness in previously healthy Melanesian adults in Papua New ...
Cryptococcal meningitis Cryptococcal meningitis is an opportunistic fungal infection, which is the number two killer of people ...
MSF responds to new WHO treatment guidelines for HIV-related cryptococcal meningitis > News , Apr 20, 2022 ... MSF Responds to Meningitis C Outbreaks in Nigeria and Niger MSF Responds to Meningitis C Outbreaks in Nigeria and Niger >Read ... Nigeria: Tackling a Massive Outbreak in the Meningitis Belt Nigeria: Tackling a Massive Outbreak in the Meningitis Belt > ... MSF responds to new WHO treatment guidelines for HIV-related cryptococcal meningitis >Read More ...
Oral Amphotericin B May Be Effective in HIV-Associated Cryptococcal Meningitis. Antifungal activity and survival rates were ... similar between patients with HIV-associated cryptococcal meningitis who received oral lipid nanocrystal amphotericin B vs ... to rarer ones such as central nervous system infections like meningitis (in less than 0.2% of people) and respiratory cancers ...
... meningitis, or meningoencephalitis. In addition, cryptococcosis is the most common fungal disease in HIV -infected persons, and ... The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis. J Clin Microbiol. 2005 Nov. 43( ... Cryptococcal meningitis (C. neoformans var. gattii) leading to blindness in previously healthy Melanesian adults in Papua New ... Of patients with AIDS in the United States, cryptococcal meningitis occurs more commonly in African Americans than in whites. [ ...
... ) 下午2:57:00 頭痛 發燒 脖子僵硬 (neck stiffness) 都是 腦膜炎 (menigitis) 的典型症狀》感染性腦膜炎可以是細菌 黴菌
Cryptococcal meningitis - understanding a deadly brain fungus. Dr Gifford is a Paediatric Specialty Trainee with a passion for ... What is Cryptococcus and who does it affect? How does it causes meningitis and what is the difference in the disease between ...
Cryptococcal Meningitis. Indicated for treatment of Cryptococcal meningitis in HIV-infected patients ... Cryptococcal Meningitis. Indicated for treatment of Cryptococcal meningitis in HIV-infected patients ...
Toward Simpler, Safer Treatment of Cryptococcal Meningitis. N Engl J Med 2022;386:1179-1181.. PMID: 35320648 ...
  • Single-dose liposomal amphotericin B combined with flucytosine and fluconazole was noninferior to the WHO-recommended treatment for HIV-associated cryptococcal meningitis and was associated with fewer adverse events,' says the study, published last month in the New England Journal of Medicine . (news-medical.net)
  • The only challenge with the implementation of these findings is that both flucytosine and liposomal amphotericin B are not readily available in the public sector in Kenya and many other Sub-Saharan countries which bear the brunt of cryptococcal meningitis,' she tells SciDev.Net . (news-medical.net)
  • Cryptococcal meningitis can be treated with antifungal drugs: amphotericin B, fluconazole or flucytosine. (hivandhepatitis.com)
  • Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis. (agnibho.com)
  • Patients completed standard cryptococcal induction therapy with 2 weeks of amphotericin B (0.7-1 mg/kg/day) in combination with high-dose fluconazole (800 mg daily). (bmj.com)
  • The same study showed no clear benefits were evident when flucytosine was added to the 2-week initial course of amphotericin B. Guidelines published in 2002 support discontinuation of suppressive therapy for cryptococcal disease if CD4 counts remain greater than 200 cells/µL but reinstitution if the CD4 counts fall to fewer than 200 cells/µL. (medscape.com)
  • Cryptococcal meningitis is a fungal infection of the tissues covering the brain and spinal cord. (medlineplus.gov)
  • People who recover from cryptococcal meningitis need long-term medicine to prevent the infection from coming back. (medlineplus.gov)
  • According to estimates produced by the London School of Hygiene and Tropical Medicine, cryptococcal meningitis, a fungal infection which invades the lining of the brain, kills over 180,00 every year globally, with 75 per cent of deaths occurring in Sub-Saharan Africa. (news-medical.net)
  • Jarvis says: 'If the findings of the study are widely implemented across Africa, the new single-dose treatment is likely to make treatment of this severe infection in patients with advanced HIV disease easy and contribute to global efforts to reduce or eliminate deaths from cryptococcal meningitis by 2030. (news-medical.net)
  • A large-scale clinical trial has demonstrated the efficacy of a new therapeutic protocol to treat cryptococcal meningitis associated with HIV infection and shown that it leads to fewer adverse effects. (pasteur.fr)
  • Cryptococcal meningitis is a severe invasive fungal infection caused by a yeast. (pasteur.fr)
  • Meningitis is an infection of the membranes covering the brain and spinal cord. (stlukes-stl.com)
  • Cryptococcosis is a fungal infection caused by Cryptococcus neoformans that causes life-threatening meningitis. (hivandhepatitis.com)
  • Like other infections, HIV infection increases risk of meningitis, a serious condition with possible deleterious outcomes. (medscape.com)
  • An early form of aseptic, HIV-associated meningitis develops within days to weeks after HIV infection. (medscape.com)
  • The prognosis in patients with HIV-associated meningitis depends on the etiology of meningitis, the stage of HIV infection, and the availability of treatments. (medscape.com)
  • It is both sensitive and specific and a positive result strongly suggests cryptococcal infection.Any patient with a positive serum CRAG, even without any symptoms, should undergo lumber puncture to exclude cryptococcal meningitis. (agnibho.com)
  • Cryptococcal meningitis is an opportunistic fungal infection, which is the number two killer of people living with HIV/AIDS after tuberculosis. (msfaccess.org)
  • In high-resource countries, meningitis usually results from reactivated infection. (msdmanuals.com)
  • Because tuberculous meningitis has a rapid and destructive course and because diagnostic tests are limited, this infection should be treated based on clinical suspicion. (msdmanuals.com)
  • Cryptococcal meningitis (CM) is a major cause of mortality for individuals with HIV infection in Africa. (bmj.com)
  • In patients who are co-infected with HIV and C neoformans, the therapeutic goal may differ from that in patients with cryptococcal infection uncomplicated by HIV infection. (medscape.com)
  • For cryptococcal infections in patients with concomitant HIV infection who have a CD4 count of less than 200 cells/μL, the therapeutic goal is to control the acute infection, followed by life-long suppression of C neoformans . (medscape.com)
  • For patients with cryptococcal disease not complicated by HIV infection, the therapeutic goal is to achieve a permanent cure of the fungal infection so that no chronic suppressive therapy is necessary. (medscape.com)
  • Autocrine IL-10 Signaling Promotes Dendritic Cell Type-2 Activation and Persistence of Murine Cryptococcal Lung Infection. (umassmed.edu)
  • In patients with subacute meningitis, CSF examination constitutes the critical step in documenting the presence or absence of a CNS infection and the type of infecting organism. (medscape.com)
  • The incidence of cryptococcal infection in the United States has been estimated at 0.4-1.3 cases/100,000/year. (cdc.gov)
  • Cryptococcal infection is presumed to be chronic. (cdc.gov)
  • Cryptococcal disease is an opportunistic infection that occurs primarily among people with advanced HIV disease and is an important cause of morbidity and mortality in this group. (bvsalud.org)
  • All study participants had been diagnosed with a first episode of cryptococcal meningitis. (hivandhepatitis.com)
  • In most cases, cryptococcal meningitis is caused by the fungus Cryptococcus neoformans . (medlineplus.gov)
  • Cryptococcus gattii can also cause meningitis, but this form can cause disease in patients with a normal immune system as well. (medlineplus.gov)
  • Cryptococcus gattii can also cause meningitis. (stlukes-stl.com)
  • Intracranial hypertension (ICH) is responsible for both early mortality and the auditory, visual, and cognitive sequelae of meningitis caused by Cryptococcus neoformans 1 1 Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud G et al. (scielo.br)
  • Cryptococcal antigen tests were positive and Cryptococcus neoformans was cultured from the albumin-treated cerebrospinal fluid specimens and from the albumin solution. (academicoo.com)
  • In a 2016 study of patients with AIDS-associated cryptococcal meningitis, the addition of dexamethasone did not reduce mortality, was associated with more adverse events and disability, and resulted in slower clearance of Cryptococcus from the spinal fluid. (medscape.com)
  • Cryptococcus neoformans is a pathogenic yeast species that is one of the leading causes of Cryptococcal meningitis. (mtsu.edu)
  • Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species. (umassmed.edu)
  • Although this organism is genetically related to Cryptococcus neoformans , a cause of meningitis in HIV-infected persons, Cryptococcus gattii is frequently associated with a different spectrum of disease, prominently pneumonia. (cdc.gov)
  • Cryptococcus is a ubiquitous fungal pathogen that causes primarily meningitis and pneumonia. (cdc.gov)
  • Zeiger, Roni F.. "Cryptococcosis (cryptococcal Meningitis). (unboundmedicine.com)
  • Patients who have AIDS and cryptococcal meningitis account for more than 80% of the patients with cryptococcosis. (medscape.com)
  • Factors Affecting Mortality Among HIV Positive Patients Two Years after Completing Recommended Therapy for Cryptococcal Meningitis in Uganda. (aidshealth.org)
  • In sub-Saharan Africa, short-term mortality from HIV-associated meningitis is high. (medscape.com)
  • Cryptococcal meningitis is a major cause of mortality in immunocompromised patients. (agnibho.com)
  • Chen J, Zhang R, Shen Y, Liu L, Qi T, Wang Z, Mehraj V, Routy JP, Lu H. Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV-infected patients with cryptococcal meningitis.HIV Med. (agnibho.com)
  • Currently available data on the prevalence, incidence, aetiologies and mortality of cryptococcal meningitis across Africa are sparse and of limited quality. (ox.ac.uk)
  • Heterogeneity across studies will be assessed using the χ2test on Cochrane's Q statistic and a random effect meta-analysis will be used to estimate the overall prevalence, incidence density and mortality of cryptococcal meningitis across studies with similar characteristics. (ox.ac.uk)
  • Early initiation of antiretroviral therapy (ART) has been shown to decrease mortality in a number of opportunistic infections such as tuberculosis (TB) and Pneumocystis jirovicii pneumonia, but may increase mortality in central nervous system-related opportunistic infections such as TB meningitis. (bmj.com)
  • Early ART was also not favourable for those with a lower mortality risk, such as those with a lower CSF cryptococcal antigen titre after 7 days of antifungal therapy. (bmj.com)
  • This form of meningitis, which begins with the inhalation of yeast spores, has a significant mortality rate of 81% percent, with high incidence in those who are immunocompromised. (mtsu.edu)
  • Bacterial meningitis (including meningococcal meningitis , Haemophilus influenzae meningitis , and staphylococcal meningitis ) is a neurologic emergency that is associated with significant morbidity and mortality. (medscape.com)
  • Management of cryptococcal meningitis with extremely high intracranial pressure in HIV-infected patients. (scielo.br)
  • The management of cryptococcal meningitis requires medical as well as supportive cares. (agnibho.com)
  • Medical management of cryptococcal meningitis involves three phases - induction phase, consolidation phase and maintenance phase. (agnibho.com)
  • This form of meningitis starts slowly, over a few days to a few weeks. (medlineplus.gov)
  • Antifungal medicines are used to treat this form of meningitis. (medlineplus.gov)
  • Most commonly, C. neoformans causes the form of meningitis called cryptococcal meningitis. (encyclopedia.com)
  • Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. (scielo.br)
  • Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. (scielo.br)
  • A pseudooutbreak of cryptococcal meningitis was caused by the use of contaminated albumin solution used in the preparation of Papanicolaou-stained slides of cerebrospinal fluid. (academicoo.com)
  • A lumbar puncture, in which a needle is inserted into the spinal canal to collect a sample of cerebrospinal fluid (CSF), can diagnose or exclude meningitis. (wikipedia.org)
  • In acute meningitis, regardless of presentation, a lumbar puncture (LP) and cerebrospinal fluid (CSF) examination are indicated to identify the causative organism and, in bacterial meningitis, the antibiotic sensitivities. (medscape.com)
  • Picardeau M. Diagnosis and epidemiology meningitis is the second leading cause of leptospirosis. (cdc.gov)
  • The unit is also involved in the design and development of an innovative antigen diagnostic approach based on a quantitative PCR method that will facilitate diagnosis and monitoring of patients receiving treatment for cryptococcal meningitis. (pasteur.fr)
  • Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. (scielo.br)
  • Patients with aseptic meningitis, a diagnosis of exclusion, have a good prognosis and do not require any specific treatment. (medscape.com)
  • The CSF sample should be sent for Indian ink preparation and fungal culture to establish the diagnosis of cryptococcal meningitis. (agnibho.com)
  • Diagnosis of tuberculous meningitis may be difficult. (msdmanuals.com)
  • An automated rapid nucleic acid amplification test called Xpert MTB/RIF has been recommended by the World Health Organization (WHO) for the diagnosis of tuberculous meningitis. (msdmanuals.com)
  • Patients of both sexes, with no age limit with a diagnosis of cryptococcal meningitis infected with HIV from the Institute of Tropical Medicine (IMT) in 2019 were included in the study. (bvsalud.org)
  • A sample of 43 patients with a diagnosis of cryptococcal meningitis associated with HIV was studied, of these, 72.09% were male. (bvsalud.org)
  • The results of the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) study were presented at the 9th International AIDS Society Conference on HIV Science (IAS 2017) last month in Paris. (hivandhepatitis.com)
  • We propose to conduct the first systematic review to summarise the epidemiological data available on cryptococcal meningitis and its aetiological causes in Africa.Methods and analysisWe will search PubMed, MEDLINE, Excerpta Medica Database, ISI Web of Science, Africa Index Medicus, Cumulative Index to Nursing and Allied Health for studies on cryptococcal meningitis published between 1st January 1950 and 31st December 2017, involving adults and/or children residing in Africa. (ox.ac.uk)
  • Joseph Jarvis, lead author and a research associate at the Botswana Harvard AIDS Partnership Institute, says that cryptococcal meningitis is a severe disease in people with HIV, and is the most common cause of meningitis in adults, especially in East and Southern Africa. (news-medical.net)
  • Elevation of intracranial pressure in acute AIDS-related cryptococcal meningitis. (scielo.br)
  • Cryptococcal meningitis is one of the AIDS-defining illnesses. (medscape.com)
  • In addition to these specific causes of meningitis, evidence suggests that AIDS patients are also more likely than the general population to develop community-acquired bacterial or viral meningitides. (medscape.com)
  • IntroductionCryptococcal meningitis is a neglected disease and an AIDS-defining illness, responsible for 15% of all AIDS-related deaths globally. (ox.ac.uk)
  • But it also causes Cryptococcal meningitis, a leading cause of death for HIV/AIDS patients in sub-Saharan Africa. (cnn.com)
  • For suppression of relapse of cryptococcal meningitis in children with aids. (wbrs.org)
  • The study adds: 'Because this clinical trial involving HIV-positive adults with cryptococcal meningitis was conducted in a range of healthcare settings across five countries in Southern and Eastern Africa with no loss to follow-up, our results are likely to be generalizable to other African settings with a high prevalence of HIV. (news-medical.net)
  • Meningitis, Africa rological and molecular features. (cdc.gov)
  • The findings open up the possibility of more widespread treatment for cryptococcal meningitis, one of the major causes of death among people with HIV in sub-Saharan Africa. (hivandhepatitis.com)
  • Outbreaks of bacterial meningitis occur between December and June each year in an area of sub-Saharan Africa known as the meningitis belt. (wikipedia.org)
  • In 2014, the estimated number of incident cryptococcal meningitis cases was 223 100, with 73% of them occurring in Africa. (ox.ac.uk)
  • Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis. (bvsalud.org)
  • It is the largest randomized clinical trial to have been conducted, including 844 advanced-stage HIV patients presenting with cryptococcal meningitis. (pasteur.fr)
  • To verify the relationship between intracranial pressure and flash visual evoked potentials (F-VEP) in patients with cryptococcal meningitis. (scielo.br)
  • The intracranial pressure measured by spinal tap manometry showed strong positive association with the N2 latency F-VEP in patients with cryptococcal meningitis. (scielo.br)
  • More than half of the patients with cryptococcal meningitis (CM) exhibit ICH 1 1 Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud G et al. (scielo.br)
  • In the United States, the most common known cause of HIV-associated meningitis is cryptococcal meningitis, affecting 30% of patients with HIV-associated meningitis. (medscape.com)
  • Of note, 43% of patients with HIV-associated meningitis do not have identifiable etiology. (medscape.com)
  • The ASTRO-CM dose-finding pilot study investigated the role of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis in HIV-infected Ugandan patients. (umn.edu)
  • For patients infected with HIV who have successfully completed an initial course of therapy, remain free of symptoms of cryptococcal disease, and reconstitute their CD4 count to more than 200 CD4 cells/μL for more than 6 months, some authorities suggest that suppressive therapy may be discontinued. (medscape.com)
  • To reduce this risk, WHO recommends that these patients receive a "package of care" that includes testing for and prevention of the most common serious infections that can cause death, such as tuberculosis and cryptococcal meningitis, in addition to ART. (who.int)
  • To describe epidemiologically patients with HIV-associated cryptococcal meningitis from the Institute of Tropical Medicine in 2019. (bvsalud.org)
  • Urgent action is needed to improve access to the antifungal drug flucytosine, say investigators, following the presentation of the results of a trial showing that treatment containing flucytosine is superior to any other form of therapy in reducing the risk of death from cryptococcal meningitis in people with very advanced HIV disease. (hivandhepatitis.com)
  • Meningitis is acute or chronic inflammation of the protective membranes covering the brain and spinal cord, collectively called the meninges. (wikipedia.org)
  • Overview of Meningitis Meningitis is inflammation of the meninges and subarachnoid space. (msdmanuals.com)
  • In this study we described the epidemiological data on Bacterial meningitis in under-five children at Gondar University Hospital from 2012-2021. (bvsalud.org)
  • In adults, the most common symptom of meningitis is a severe headache, occurring in almost 90% of cases of bacterial meningitis, followed by neck stiffness (the inability to flex the neck forward passively due to increased neck muscle tone and stiffness). (wikipedia.org)
  • however, all three features are present in only 44-46% of bacterial meningitis cases. (wikipedia.org)
  • Neck stiffness occurs in 70% of bacterial meningitis in adults. (wikipedia.org)
  • The LP is repeated if necessary to rule out partially treated bacterial meningitis. (medscape.com)
  • Introduction: Acute Bacterial meningitis is still a major cause of death in under-five children. (bvsalud.org)
  • Surveillance on Pediatric Bacterial Meningitis has been set up by the World Health Organization to generate data on vaccine preventable causes of Meningitis in under-five children. (bvsalud.org)
  • All under-five children with suspected meningitis over the 10-years period were included and descriptive statistics like frequency, percentage, mean, median and standard deviations were used for the characteristics of under-five Children with Suspected Bacterial Meningitis. (bvsalud.org)
  • Results: In this study, a total of 4311 under-five admitted with suspected bacterial meningitis from 2012 to 2021 were enrolled. (bvsalud.org)
  • Pharmacodynamics of flubendazole for cryptococcal meningoencephalitis: repurposing and reformulation of an anti-parasitic agent for a neglected fungal disease. (liverpool.ac.uk)
  • Talk with your doctor, test Your Infectious Disease IQ What is meningitis and what causes. (njacs.org)
  • In regions with high HIV prevalence, use of novel lateral-flow diagnostic for cryptococcal disease has opened the door to systematic screening and point-of-care testing in asymptomatic persons with low CD4 cell counts and may result in reduction of deaths caused by this disease. (cdc.gov)
  • By far the most common presentation of cryptococcal disease is cryptococcal meningitis, which accounts for an estimated 15% o. (bvsalud.org)
  • Describir epidemiológicamente a los pacientes con meningitis criptocócica asociada al VIH del Instituto de Medicina Tropical en el año 2019. (bvsalud.org)
  • Estudio observacional descriptivo, retrospectivo en el que se incluyeron pacientes de ambos sexos, sin límite de edad con diagnóstico de meningitis criptocócica infectados por el VIH del Instituto de Medicina tropical (IMT) en el año 2019. (bvsalud.org)
  • A lumbar puncture ( spinal tap ) is used to diagnose meningitis. (medlineplus.gov)
  • Each patient of cryptococcal meningitis should undergo repeated therapeutic lumbar puncture to relieve the CSF pressure lp . (agnibho.com)
  • An article published in the New England Journal of Medicine in March 2022 proposed an innovative treatment approach for cryptococcal meningitis. (pasteur.fr)
  • The review, published in The Lancet Infectious Diseases , estimated that 6% of people living with HIV with CD4 cell counts below 100 cells/mm 3 are positive for cryptococcal antigen, which strongly predicts the development of cryptococcal meningitis. (hivandhepatitis.com)
  • Meningitis caused by the bacterium Neisseria meningitidis (known as "meningococcal meningitis") can be differentiated from meningitis with other causes by a rapidly spreading petechial rash, which may precede other symptoms. (wikipedia.org)
  • A new short-course treatment is effective against HIV-associated cryptococcal meningitis with fewer serious side effects, and has the potential to reduce the length and cost of hospital admissions, a study shows. (news-medical.net)
  • Isavuconazole Is Effective for the Treatment of Experimental Cryptococcal Meningitis. (qxmd.com)
  • Globally, the burden of cryptococcal meningitis remains high despite recent advances in HIV detection and treatment, with an estimated 223,100 incidence cases in 2014. (medscape.com)
  • Without treatment cryptococcal meningitis is always fatal. (agnibho.com)
  • The first treatment in acute meningitis consists of promptly giving antibiotics and sometimes antiviral drugs. (wikipedia.org)
  • This study is expected to provide useful contextual estimates needed to inform treatment policies on the African continent and assess the impact of diagnostic and prevention strategies on the burden of cryptococcal meningitis in the post antiretroviral therapy era.PROSPERO registration numberCRD42017081312. (ox.ac.uk)
  • Toward Simpler, Safer Treatment of Cryptococcal Meningitis. (amedeo.com)
  • Treatment for cryptococcal meningitis usually includes anti-fungal drugs such as fluconazole. (encyclopedia.com)
  • A systematic review calculated the numbers to be 44%, 46%, and 54% from cryptococcal meningitis, TB meningitis and pneumococcal meningitis, respectively. (medscape.com)
  • Cryptococcal meningitis ( neoformans var. (cdc.gov)
  • C. neoformans variety neoformans causes most of the cryptococcal infections in humans. (encyclopedia.com)
  • La mayoría son causados por C. neoformans (serotipos A y D). C. neoformanses un patógeno oportunista en pacientes con SIDA. (bvsalud.org)
  • Marybeth Cherono Maritim, a senior lecturer at the University of Nairobi's Department of Clinical Medicine and Therapeutics, says the study has positive implications for treating HIV-associated meningitis because the regimen is safe and efficacious. (news-medical.net)
  • Initial therapy should be considered successful only after CSF culture is negative for cryptococcal organisms and the patient has had significant clinical improvement. (medscape.com)
  • Diflucanis used for treating cryptococcal meningitis. (njacs.org)
  • 2, high-titer cryptococcal antigenemia) were treated with 800 mg/day fluconazole to assess the safety and efficacy of high-dose fluconazole as primary therapy. (curehunter.com)
  • Immune reconstitution inflammatory syndrome (IRIS) may happen with cryptococcal meningitis when there is a improvement in host immune status after initiation of anti retroviral therapy (ART). (agnibho.com)
  • The sample included adults diagnosed with cryptococcal meningitis admitted at a reference hospital for infectious diseases. (scielo.br)
  • In general, symptoms and signs typically associated with meningitis are less likely to occur in HIV-seropositive individuals than in the general population. (medscape.com)
  • Symptoms and signs are similar to those of other meningitides but more indolent. (msdmanuals.com)
  • Serum and CSF cryptococcal antigen (CRAG) is an useful test to diagnose cryptococcal meningitis. (agnibho.com)
  • NIH-PA Author Manuscript blood count, serum chemistries, CD4+ cell count assays, Rapid Plasma Reagin (RPR), and serum cryptococcal antigen (sCrAg) testing. (cdc.gov)
  • Some forms of meningitis are preventable by immunization with the meningococcal, mumps, pneumococcal, and Hib vaccines. (wikipedia.org)
  • We evaluated the efficacy of isavuconazole against cryptococcal meningitis. (qxmd.com)
  • If none of the three signs are present, acute meningitis is extremely unlikely. (wikipedia.org)
  • There was no difference in the frequency of cryptococcal IRIS, relapse of CM, fungal clearance, virological suppression at 26 weeks, significant adverse events and ART discontinuation for more than 3 days between the two groups. (bmj.com)
  • Subacute meningitis develops over days to a few weeks. (msdmanuals.com)
  • Subacute and chronic meningitis may result from a wide variety of organisms and conditions. (msdmanuals.com)
  • An immunocompromised patient presenting with severe headache for some duration should raise the suspicion of cryptococcal meningitis. (agnibho.com)
  • Other features that distinguish meningitis from less severe illnesses in young children are leg pain, cold extremities, and an abnormal skin color. (wikipedia.org)